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Abstract 
Accumulating evidence indicates that inflammation has a strong association with 
development of cancer. Inflammation is suggested to cause DNA alterations and oncogenic 
mutations resulting in tumor initiation. Inflammation promotes tumor progression via 
inflammatory cytokines released by immune cells. Cigarette smoke (CS) is the most 
important risk factor for both lung cancer and chronic obstructive lung disease (COPD).  
Clinical data indicate that COPD-related inflammation is an important risk factor for the 
development of lung cancer. The aim of this study was to investigate the role of myeloid 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) in the regulation of 
growth signalling of CS-induced pulmonary tumor growth. Furthermore, the impact of CS in 
the Wnt/-catenin signalling pathway of tumor cells was studied and it was investigated 
whether the antimicrobial peptide LL-37 has tumor promoting functions.  
In vitro, transwell inserts were used in a co-culture model to determine the impact of 
macrophages on lung cancer cells proliferation. In the co-culture model, macrophages 
increased the growth of the lung cancer cell line A549 shown by cell number count, FACS 
(carboxyfluorescein succinimidyl ester, CFSE labeling) and ELISA (5-bromodeoxyuridine, 
BrdU labeling) analysis. Furthermore, addition of cigarette smoke extract (CSE) to the co-
culture enhanced macrophage induced growth of A549 cells. Real time PCR and ELISA assay 
showed that CSE increased the secretion of inflammatory factors from macrophages and 
A549 cells. Inhibition of the NF-B pathway by a NF-B inhibitor or by RNAi against RelA 
inhibited tumor cell proliferation. 
A metastatic lung cancer mouse model which is established by intravenous injection of 
Lewis lung carcinoma cells was used to investigate lung cancer proliferation. After 
mainstream cigarette smoke (MCS) exposure, the number of tumor nodules was higher 
compared to air exposed control animals. However, in CS exposed rela
Δ-/- 
mice (deleted 
RelA/p65 in the myeloid lineage), the tumor growth was significantly lower. rela
Δ-/- 
mice 
survived longer as compared to wild type (WT) mice. CS exposure resulted in enhanced 
expression of the proliferation markers Ki-67, PCNA, c-myc, and cyclinD1 in lung tumors of 
wild type animals shown by immunoblot analysis and immunohistochemistry. This was not 
observed in rela
Δ-/- 
mice. In contrast to rela
Δ-/- 
mice, CS exposure of wild type mice resulted in 
the secretion of inflammatory factor such as IL-6, KC, and TNF as well as in the activation 
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of STAT3 and c-jun signalling in tumor cells. Additionally, CS exposure significantly 
increased the number of infiltrated macrophages in tumsaor. However, in rela
Δ-/- 
mice, 
RelA/p65 ablation did not significantly affect the recruitment of macrophage.  
To identify whether Wnt/-catenin signalling pathway is implicated in tumor-promoting 
effect of CS, regulation of unphosphorylated-cateninin were examined. Immunoblot and 
immunohistochemical analysis showed that the CS-induced activation of the Wnt/-catenin 
signaling pathway in tumor cells is dependent on RelA/p65 of myeloid cells. In vitro data 
showed that TNF-directly activates Wnt/-catenin signaling in tumor cells by inducing 
glycogen synthase kinase 3(GSK3phosphorylation and the activation of the Akt pathway.  
Antimicrobial peptides, such as cathelicidins, are key effectors of the innate immune 
system and regulate host defense and inflammation. Previously we showed that the human 
cathelicidin LL-37/hCAP-18 is a growth factor for lung cancer cells. Whether cathelicidins 
play a role in CS-promoted lung carcinoma proliferation is poorly understood. Here, it is 
demonstrated that the murine cathelicidin cathelicidin-related antimicrobial peptide (CRAMP) 
mediates lung tumor growth. CS exposure increased the proliferation of lung tumors in wild 
type mice, but not in CRAMP deficient mice. Furthermore, CS exposure induced the 
recruitment of myeloid cells into tumor tissue in a CRAMP dependent manner. Mice 
specifically lacking RelA/p65 in myeloid cells showed impaired CS-induced CRAMP-
positive myeloid cell recruitment into lung. Additionally, in vitro studies with human tissue 
showed that the CS induced LL-37/hCAP-18 expression in macrophages is mediated by 
cancer cells. The regulation of LL-37/hCAP-18 expression in macrophages induced by 
inflammation involved the vitamin D receptor and Cyp27B1 activation. 
In summary, it is shown in this study that: (i) myeloid RelA/p65 is necessary to link 
smoke-induced inflammation with lung cancer growth and the activation of Wnt/-catenin 
signaling in tumor cells; (ii) cathelicidin promotes cigarette smoke-induced lung carcinoma 
proliferation, which is associated with the recruitment of immune cells and activation of 
myeloid NF-B. 
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Zusammenfassung 
Eine Vielzahl an Studien legt nahe, dass es einen starken Zusammenhang zwischen der 
Entstehung von Krebs und Entzündung gibt. Es wird angenommen, dass Entzündungen DNA-
Veränderungen und onkogene Mutationen verursachen, was zur Initiation von Tumoren 
beiträgt. Entzündungen begünstigen Tumorprogression mittels inflammatorischer Zytokine, 
die von Immunzellen abgegeben werden. Zigarettenrauch ist sowohl für Lungenkrebs als auch 
für die COPD (chronisch obstruktive Lungenerkrankung) der größte Risikofaktor. Klinisch 
Daten besagen, dass die mit COPD verbundene Entzündung ein bedeutender Risikofaktor für 
das Entstehen von Lungenkrebs ist. Es war das Ziel dieser Studie, die Rolle myeloiden NF-
κBs bei der Regulation von Wachstumsfaktoren, die Zigarettenrauch induziertes Wachstum 
von Lungentumoren vermitteln, zu untersuchen. Es wurde darüberhinaus untersucht, ob 
Rauch den Wnt/β-catenin abhängigen Signalweg in Tumorzellen aktiviert und ob das 
antimikrobiellen Peptide LL-17 bei der Proliferation von Tumoren eine Rolle spielt   
Transwell-Inserts wurden in einem in vitro Ko-Kulturmodell genutzt, um den Einfluss von 
Makrophagen auf die Proliferation von Lungenkrebszellen zu untersuchen. Makrophagen 
steigerten das Wachstum von der Lungenkrebszellline A549 in diesem Ko-Kulturmodell, was 
mittels Zellzahl, FACS (carboxyfluorescein succinimidyl ester, CFSE labeling) und ELISA 
(5-bromodeoxyuridine, BrdU labeling) gezeigt wurde. Zigarettenrauchextrakt verstärkte 
darüber hinaus das durch Makrophagen induzierte Wachstum von A549 Zellen in diesem 
Modell. Quantitative RT-PCR und ELISA Analysen zeigten, dass Zigarettenrauchextrakt die 
Abgabe von inflammatorischen Faktoren von Makrophagen und A549 Zellen steigert. 
Inhibition des NF-κB Signalwegs mit Inhibitoren für NF-κB oder RNAi gegen RelA 
verminderten die Proliferation von Tumorzellen.      
Ein murines Metastase-Lungenkrebsmodell, das auf der intravenösen Gabe von Lewis 
Lung Carcinoma Zellen basiert, wurde genutzt, um Lungenkrebsproliferation zu untersuchen. 
Die Zahl der Tumorknoten war bei berauchten Tieren größer als bei Raumluft exponierten 
Tieren. Bei Rauch exponierten myeloid rela
Δ-/-
 defizienten Tieren (myeloid RelA/p65 war bei 
diesen Tieren ausgeschaltet) war das Tumorwachstum jedoch signifikant geringer. rela
Δ-/-
 
defiziente Tiere zeigten größere Überlebensraten im Vergleich zu Wildtyp Mäusen. 
Rauchexposition führte zu einer gesteigerten Expression der Proliferationsmarker Ki-67, 
PCNA, c-myc und Cyclin D1 in Lungentumoren von Wildtyp Tieren, was mittels 
Westernblotanalyse und immunhistochemischer Färbung gezeigt wurde. Dies wurde in rela
Δ-/-
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defizienten Tieren nicht beobachtet. Im Gegensatz zu rela
Δ-/-
 defizienten Tieren führte 
Rauchexposition bei Wildtyp Mäusen zu der Abgabe von inflammatorischen Markern wie z.B. 
IL-6, KC und TNFα und zur Aktivierung der STAT3 und c-jun Signalkaskaden in 
Tumorzellen. Rauchexposition führte in den Tumoren auch zu einer gesteigerten Zahl an 
infiltrierten Makrophagen. In relaΔ-/- defizienten Tieren hatte die Ablation von RelA/p65 
jedoch keinen Einfluss auf den Einstrom von Makrophagen in Tumorgewebe.   
Um zu untersuchen, ob der Wnt/β-catenin Signalweg an den Tumor induzierenden 
Eigenschaften von Rauch beteiligt ist, wurde die Regulation von phosphoryliertem β-catenin 
untersucht. Westernblotanalysen und immunohistochemische Färbungen zeigten, dass die 
durch Rauch induzierte Aktivierung des Wnt/β-catenin Signalwegs in Tumorzellen von 
myeloidem RelA/p65 abhängt. In vitro Studien zeigten, dass TNFα den Wnt/β-catenin 
Signalweg in Tumorzellen direkt aktiviert. Dies geschieht mittels der Phosphorylierung der 
Glycogen-Synthase-Kinase 3β (GSKβ) und der Aktivierung des Akt Signalwegs.  
Antimikrobielle Peptide wie Cathelizidine sind Schlüsselkomponenten des angeborenen 
Immunsystems und regulieren Wirtsabwehr und Entzündung. Unsere Gruppe hat bereits 
gezeigt, dass das Cathelizidin LL-37/hCAP-18 ein Wachstumsfaktor für Lungenkrebszellen 
ist. Ob Cathelizidine eine Rolle bei der durch Rauch verursachten Proliferation von 
Krebszellen eine Rolle spielt, ist nicht bekannt. In dieser Studie wird gezeigt, dass das murine 
Cathelizidin CRAMP Wachstum von Lungentumoren vermittelt. Rauch verstärkte die 
Proliferation von Lungentumoren in Wildtyp Mäusen, aber nicht in CRAMP defizienten 
Tieren. Darüberhinaus zeigte sich der Rauch induzierte Einstrom von Makrophagen CRAMP 
abhängig. Myeloid defiziente RelA/p65 Mäuse wiesen nach Rauchinkubation einen 
verminderten Einstrom von CRAMP positiven myeloiden Zellen in die Lunge auf. In vitro 
Studien mit humanem Gewebe zeigte darüber hinaus, dass die durch Rauch induzierte 
Expression von LL-17/hCAP-18 in Makrophagen durch Krebszellen vermittelt wird. An der 
Regulation der Expression von LL-37/hCAP-18 in Makrophagen bei Rauch induzierter 
Entzündung war der Vitamin D Rezeptor und Aktivierung von Cyp27B1 beteiligt. 
Insgesamt wurde in dieser Arbeit gezeigt, dass (i) myeloides RelA/p65 die Rauch 
induzierte Entzündung mit der Proliferation von Lungentumoren und der Aktvierung des 
Wnt/β-catenin Signalwegs in Tumorzellen verbindet und dass (II)  Cathelizidine die durch 
Rauch induzierte Proliferation von Carcinomen vermitteln, was mit der Rekrutierung von 
Immunzellen und der der Aktivierung myeloiden NF-κBs verbunden ist. 
(The Zusammenfassung is kindly contributed by Dr. Christoph Beisswenger)
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1 Introduction 
 
1.1 Inflammation and cancer  
‘Most things in life are a double-edged sword’ is a common wisdom, and today, it is widely 
believed that inflammation is a double-edged sword (Hagemann et al., 2007). Inflammation is 
a response to either internal or external environmental stimuli, and is a crucial function of host 
innate immunity, such as wound healing and infection (Coussens and Werb, 2002). 
Inflammation can be divided into acute inflammation and chronic inflammation. Acute 
inflammation is an initial stage of inflammation. It is a rapid and self-limiting process 
mediated by chemical mediators and immune cells. Continuous, long lasting inflammation is 
regarded as chronic inflammation (Balkwill et al., 2005). Accumulating evidence indicates 
that inflammation has a strong association with development of cancer (Grivennikov and 
Karin, 2010a). For example, cigarette smoke (CS), asbestos, and silica induce pulmonary 
inflammation and contribute to the initiation and promotion of lung cancer (Yoshimura, 2006; 
Takahashi et al., 2010). Some pulmonary inflammatory diseases such as chronic obstructive 
pulmonary disease (COPD) are associated with lung tumor development. Chronic 
inflammation induced by repetitive injury, infection with Helicobacter pylori or Hepatitis C 
virus (HCV), or by ulcerative colitis (UC) is associated with gastric cancer, liver cancer and 
colon cancer, respectively (Balkwill et al., 2005). Others inflammatory diseases, such as 
obesity-associated inflammation, may promote liver cancer (Park et al., 2010). Inflammatory 
bowel disease increases the risk of colitis-associated cancer (CAC) (Grivennikov and Karin, 
2010a). Furthermore, acute and subacute inflammation caused by exogenous administration 
of CS, tumour necrosis factor TNF, interleukin 1 (IL-1), and lipopolysaccharide (LPS) 
have been found to promote tumor growth and metastasis (Balkwill and Mantovani, 2001; 
Luo et al., 2004; Takahashi et al., 2010). Although inflammations has been implicated in 
tumor initiation, the major effect of inflammation on tumor development in experimental 
animal studies is tumor promotion (Karin and Greten, 2005; Takahashi et al., 2010). 
 
1.1.1 Immune cells in tumorigenesis 
The tumor microenvironment plays a critical role in tumor initiation and promotion and 
contains innate immune cells, lymphocytes and connective tissue, such as fibroblasts, 
endothelial cells, pericytes, and mesenchymal cells (Grivennikov et al., 2010). Innate immune 
cells (also known as myeloid cells) including macrophages, neutrophils, eosinophils, mast 
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cells, myeloid-derived suppressor cells, dendritic cells, and natural killer cells, express and 
release cytokines and chemokines and influence tunorigenesis (Yoshimura et al., 2006; 
Coussens and Werb, 2002; Grivennikov et al., 2010).  
Macrophages play a pivotal role in inflammation. Macrophages can be divided into M1 or 
M2 phenotype (Sica et al., 2008). M1 macrophages exhibit a pro-inflammatory phenotype, 
and have an ability of killing microorganisms and reveal antitumor activity. They produce 
copious amounts of pro-inflammatory cytokines (e.g. TNF, IL-1, IL-6, IL-12 or IL-23), 
express major histocompatibility complex (MCH) molecules, and inducible nitric oxide 
synthase and are activated by microbial products and interferon  (IFN) (Hagemann et al., 
2009; Sica et al., 2008). In contrast, M2 macrophages which are induced by IL-4, IL-10, IL-
13, glucocorticoid hormones, and vitamin D3 have an immunosuppressive phenotype and 
release cytokines that tune inflammatory response, promote angiogenesis, tissue remodelling, 
and cell proliferation (Hagemann et al., 2009; Mantovani et al., 2002; Murdoch et al., 2008). 
However, several studies have shown that ‘‘M1 cytokines’’ are also capable of promoting 
tumor proliferation, whereas some ‘‘M2 cytokines’’, such as IL-10, may inhibits tumor 
growth (Lin and Karin, 2007; Grivennikov et al., 2010). 
Tumor-associated macrophages (TAMs) are an important component of inflammatory 
infiltrates in tumors and are derived from circulating monocytic precursors by 
chemoattractants, such as vascular endothelial growth factor, CXCL12 (SDF1) and monocyte 
chemotactic protein (MCP), secreted by both tumor and stromal cells (Mantovani et al., 2002; 
Pollard, 2004). Most solid tumors are abundantly populated with TAMs and these cells are 
mostly regarded as tumor promoters (Bingle et al., 2002). Clinical studies have confirmed that 
high populations of TAMs generally correlate with poor prognosis in lung, breast, prostate, 
ovarian, and cervical cancers (Koukourakis et al., 1998; Bingle et al., 2002; Hagemann et al., 
2009). TAMs generally have a M2 phenotype and function, which promotes tumor cell 
proliferation, tissue remodelling, and angiogenesis (Mantovani et al., 2008). For example, 
TAMs downregulate MHC class II and IL-12 expression and increase expression of the anti-
inflammatory cytokine IL-10, scavenger receptor A and arginase-1(Arg-1), display a poor 
antimicrobial and tumoricidal activity (Grivennikov et al., 2010). Moreover, TAMs also 
express factors that promote angiogenesis, such as vascular endothelial growth factor (VEGF) 
and cyclo-oxygenase-2 (COX-2)–derived prostaglandin E2 (Hagemann et al., 2009; Sica et al., 
2008). However, accumulating evidence indicates that TAMs also have M1 characteristics 
which expressing ‘M1 cytokines’ such as TNF, IL-1, and IL-6, and M1 macrophages 
enzyme (iNOS or NOS2,) (Grivennikov et al., 2010; Kusmartsev and Gabrilovich, 2005; Tsai 
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et al., 2007). Recent evidence has suggested that TAMs are plastic and their phenotype is 
variable with the stage of tumor development, and generally considered to be M1 phenotype 
as tumor initiation and M2 phenotype while tumor promotion (Murdoch et al., 2008). 
There is a growing body of evidence that TAMs promote the growth and survival of 
tumors, angiogenesis, invasion and metastases (Balkwill and Mantovani, 2001). In 
macrophage-deficient mice, tumor progression and metastatic ability were impaired and 
tumor growth was completed inhibited. This was associated with an increased survival rate in 
these mice (Lin et al., 2001; Aharinejad et al., 2002). TAMs produce high levels of potent 
angiogenic and lymphangiogenic growth factors, cytokines and proteases which support 
tumor progression (Sica et al., 2008). For example, the release of platelet derived growth 
factor (PDGF) from TAMs contributes to stroma formation and angiogenesis resulting in lung 
cancer promotion (Kataki et al., 2002). Moreover, TAMs release TNF, IL-6, IL-1, TGF, 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), hepatocyte 
growth factor (HGF) and epidermal- growth-factor receptor (EGFR)-family ligands, all of 
which are implicated in tumor proliferation and angiogenesis (Pollard, 2004; Murdoch et al., 
2008). TAMs also produce matrix-metalloproteases (e.g. MMP7, MMP9), which digest the 
extracellular matrix and break basement membrane, leading to tumor invasion (Pollard, 2004; 
Murdoch et al., 2008). In addition, TAMs can also inhibit antigen presentation of dendritic 
cells and induce T regulatory (Treg) cells through production of IL-10 and transforming 
growth factor (TGF) leading to immunosuppression that favours tumor promotion 
(Yoshimura, 2006). TAMs also suppress tumor-infiltrating T cell antitumor function by 
expression of hypoxia-inducible factor-1 thereby promoting breast tumor progression 
(Doedens et al., 2010). 
There are also other immune cells that affect tumorigenesis. Many T cell subsets, such as 
CD8
+
 T cells, IFN-producing Th1 cells, Th2 cells, Th17 cells, and Treg cells, are found to be 
involved in tumor promotion, progression, or metastasis in solid tumors (Grivennikov et al., 
2010). It has been displayed that recruitment of Treg cells promotes lung carcinogenesis, 
which through suppressing T cell-mediated antitumor activity and regulation of 
immunosuppressive cytokine profile (Zaynagetdinov et al., 2011; Tao et al., 2012). In breast 
cancer, an increase in T cells with high CD4
+
/CD8
+
 and Th2/Th1 ratios is predictive of poor 
prognosis (Grivennikov et al., 2010). In melanoma and bladder cancers, IL-17 which is 
released by Th17 cells can promote tumor growth through an IL-6-Stat3 signalling pathway 
(Wang et al., 2009). Immature dendritic cells (iDC) in tumors promote tumor angiogenesis by 
secretion of pro-angiogenic cytokines, including TNF, CXCL8 (IL-8), and VEGF (Murdoch 
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et al., 2008). In patients with bronchioloalveolar carcinoma, increased neutrophil numbers are 
correlated with poor prognosis. Tumor associated neutrophils promote tumor neo-
vascularization and tumor development by production of cytokines, chemokines, proteases 
and ROS, including VEGF, MMP9, CXCL8, and CXCL1 (Murdoch et al., 2008; Fridlender et 
al., 2009).  
 
1.1.2 Soluble mediators of inflammation in tumorigenesis 
The inflammatory cytokine, chemokine, and enzymes expression profile of the tumor 
microenvironment is rich including TNF, IL-6, IL-8, and MMPs and may be implicate in 
inflammation-associated tumor growth (Balkwill and Mantovani, 2001; Coussens and Werb, 
2002). TNF has a critical role in inflammatory reactions which are induced by a wide range 
of pathogenic stimuli. TNF induces other inflammatory mediators and proteases that 
orchestrate inflammatory responses (Balkwill, 2002; Aggarwal et al., 2006). TNF was 
initially described as a tumor killer. A high dose of TNF selectively destroys tumor blood 
vessels and can stimulate anti-cancer immunity (Balkwill, 2002). However, a number of 
reports indicate that TNF is also likely to be an important tumor-promoting cytokine 
contributing to the development of tumors (Aggarwal et al., 2006). TNF production can be 
detected in various human cancers, such as lung carcinoma, ovarian carcinoma, renal 
carcinoma, CAC carcinoma, and breast carcinoma. Its presence is generally associated with a 
poor prognosis (Balkwill et al., 2005; Aggarwal et al., 2006). In the tumor microenvironment, 
TNF is produced by inflammatory cells or tumor cells, supporting tumor proliferation and 
survival by activation of AP-1 and NF-κB signalling pathways (Grivennikov and Karin, 2011). 
TNF is involved in tumor initiation by inducing the production of reactive oxygen and NO 
which leads to DNA damage and mutations (Balkwill, 2002). Exposure to 0.6 nM TNF 
markedly enhanced transformation of BALB/3T3 cells initiated with 3-methylcholanthrene 
(Komori et al., 1993).  In vivo, macrophages phagocytize asbestos and release TNF that are 
susceptible to malignant transformation in asbestos-induced human malignant mesothelioma 
(Yang et al., 2006a). TNF enhances tumor progression, including promotion of proliferation, 
angiogenesis, and invasion. For instance, TNFcan induces the expression of amphiregulin, 
EGFR, and TGF in tumor cells, which mediate the proliferation of cells (Aggarwal et al., 
2006). TNFalso induces angiogenic factors, such as VEGF, as well as the production of 
proteases that are important for invasion of tumor cells and macrophages, such matrix 
metalloproteases 9 (MMP9) (Balkwill and Mantovani, 2001). 
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The tumor-promoting effect of TNF has been demonstrated in mice deficient in TNF 
that showed markedly reduced lung tumor multiplicity and mortality after inoculation with 
Lewis lung carcinoma (LLC) cells (Kim et al., 2009). In another tumor transplantation model 
of lung cancer, TNFR1 deficiency led to depressed hepatocyte growth factor (HGF) 
expression and neovascularization resulting in apoptosis of tumor cells (Tomita et al., 2004). 
TNF from host macrophages promotes LPS induced colon adenocarcinoma cell line growth 
in a mouse lung metastasis model by activation of NF-B in tumor cells (Luo et al., 2004). 
TNF deficient mice are resistant to carcinogen (7,12-dimethylbenz(a)anthracene) induced 
skin cancer (Moore et al., 1999). Deficiency of TNFR1 and TNFR1 in mice has also been 
found to reduce carcinogenesis of skin (Arnott et al., 2004).  In a Mdr2-knockout model of 
Hepatocellular carcinoma (HCC), TNF released by inflammatory cells promotes tumor 
development through activating NFB in hepatocytes (Pikarsky et al., 2004). TNF 
expression is upregulated during colitis accociated cancer (CAC) and lacking of TNFR1 or 
administration of etanercept, a specific antagonist of TNF results in decreased 
tumorigenicity and tumor growth (Popivanova et al., 2008). 
IL-6 is a key inflammatory cytokine that is important for immune responses, cell survival, 
apoptosis, and proliferation through activation of Janus kinases (JAKs) and the downstream 
effectors signal transducers and activators of transcription factors 3 (STAT3), Shp2-Ras, and 
phosphatidylinositol 3-kinase (PI3K)-Akt (Grivennikov et al., 2009). The role of IL-6 in 
malignant cell proliferation and survival has been well documented. Elevated IL-6 expression 
levels in serum and tumor are associated with the pathogenesis of several cancers, including 
lung, breast, prostate, liver, ovarian, and colon cancers, and in general, this is correlated with 
an unfavourable outcome (Heikkila et al., 2008, Balkwill et al., 2005). In lung carcinoma, 
constitutively activation of STAT3 induced by IL-6 has been observed, which is important for 
development, proliferation, and survival of tumor cells (Hodge et al., 2005). In CAC, lamina 
propria myeloid cell derived IL-6 promotes proliferation of tumor cells and protects normal 
and premalignant intestinal epithelial cells from apoptosis (Grivennikov et al., 2009). 
Ablation of IL-6 in mice results in a decreased tumor number and a smaller tumor size in an 
azoxymethane dextran sulphate sodium induced CAC mouse model (Grivennikov et al., 
2009). 
Other important soluble mediators of inflammation also induce tumorigenesis and 
promotion of tumor, including IL-1, IL-8, and MMPs (Aggarwal et al., 2006, Balkwill et al., 
2005). IL-1 increases lung tumor growth by promoting the expression of several angiogenic 
factors in tumors and stromal cells (Balkwill et al., 2005). IL-8 has been reported to promote 
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growth and metastasis of several cancers including lung cancer, melanoma, and ovarian 
cancer (Aggarwal et al., 2006, Takahashi et al., 2010). Activation of K-ras in lung 
adenocarcinoma cells results in upregulation of IL-8. Autocrine production of IL-8 stimulates 
tumor inflammation, angiogenesis, and growth (Takahashi et al., 2010, Karin, 2005). Alveolar 
endothelial cell or TAM-induced MMP9 significantly promotes lung metastasis in tumor 
bearing mice dependent upon VEGFR-1/Flt-1 tyrosine kinase (VEGFR-1TK) (Hiratsuka et al., 
2002). Reduced lung metastasis was also found in mice deficient in either MMP9 or VEGFR-
1TK (Hiratsuka et al., 2002). MMP12 overexpression in lung epithelial cells induces 
emphysema to lung adenocarcinoma transition via upregulation of IL-6 and activation of 
STAT3 downstream of IL-6 (Qu et al., 2009). 
 
1.1.3 Inflammation and tumor initiation 
Carcinogenesis contains three stages: initiation, promotion, and progression, all are associated 
with inflammation (Fig. 1). Approximately 25% of cancer cases worldwide is associated with 
chronic infection and inflammation (Kundu and Surh, 2008). Growing evidence suggests that 
chronic inflammation induced by persistent stimulus might enhance tumor initiation, such as 
smoking, silica, asbestos, bacteria, and virus (Coussens and Werb, 2002).  A strong 
association of chronic inflammation and tumor initiation has been shown in a model of 
colonic irritant dextran sodium sulphate (DSS) induced colitis. It was suggested that chronic 
inflammation can directly induce DNA damage and mutation and cause colitis-associated 
cancer (Meria et al., 2008). Various inflammatory cells infiltrate the site of infection or 
inflammation and induce DNA damage and genomic instability in proliferating cells through 
generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Karin and 
Greten, 2005). Some cytokines, such as TNF produced by inflammatory cells can induce 
ROS accumulation in epithelial cells (Grivennikov et al., 2010). It has been suggested that 
TNF is a transforming agent and NO might be involved in the molecular mechanism of 
carcinogenesis (Balkwill and Mantovani, 2001). In Helicobacter pylori induced gastric and 
TNF induced pulmonary carcinogenesis, a major biochemical hallmark is oxidative and 
mutagenic DNA damage (8-Oxo-7,8-dihydro-2’-deoxyguanosine) has been found (Coussens 
and Werb, 2002). Moreover, chronic inflammation induces oxidative damage and causes p53 
mutation, resulting in p53 functional inactivation suggesting that chronic inflammation 
involves in tumor initiation (Balkwill and Mantovani, 2001).  
Another mechanism through which inflammation might contribute to tumor initiation 
involves the up-regulation of activation-induced cytidine deaminase (AID). AID is an enzyme 
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induced by inflammatory cytokines in an NF-B-dependent manner or by TGF, which 
induces genomic instability and increases mutation of critical tumor genes, such as Tp53, c-
Myc, and Bcl-6. (Okazaki et al., 2007; Colotta et al., 2009). Furthermore, DNA damage 
induces cell death resulting in tumor initiation. In carcinogen diethylnitrosamine (DEN) 
induced hepatocellular carcinoma model, DEN causes hepatocyte DNA damage and 
contributes to necrotic cell death leading to inflammation and thereby promotes tumorigenesis 
(Maeda et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.4 Inflammation and tumor promotion  
A single initiated cell undergoes proliferation to form a fully developed primary tumor, a 
process that is generally termed tumor promotion. Increased malignant cell proliferation and 
reduced malignant cell death result in tumor promotion, both are strongly modulated by 
various inflammatory mediators produced by immune cells from the tumor microenvironment 
Figure 1: Role of inflammation in 
tumour carcinogenesis.  
Inflammation acts at all phases of 
carcinogenesis. Reactive oxygen species 
(ROS) and reactive nitrogen intermediates 
(RNI) produced by immune /inflammatory 
cells contribute to tumor initiation by 
inducing DNA damage, mutations, 
genomic instability, and epigenetic modi-
fications. During the second phase of 
carcinogenesis, cytokines and chemokines 
produced by immune and inflammatory 
cells increase tumur cells survival, growth 
and angiogenesis. As parts of positive 
feed-forward loops, cytokines and 
chemkines attract additional immune 
/inflammatory cells to the tumur micro-
environment supporting tumur promotion. 
Finally, in the progression phase, immune 
cells further produce cytokines and 
chemkines to increase cancer cell survival, 
motility, invasion and epithelial 
mesenchymal transition (EMT) (adapted 
from Grivennikov and Karin, 2010).  
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(Grivennikov and Karin, 2010a; Kundu and Surh, 2008). The tumor promoting effect of 
inflammation is well understood and inflammation is suggested to be implicated in tumor 
initiation. In animal models, the major enhancing effects of inflammation on tumors are 
exerted at the level of tumor promotion (Takahashi et al., 2010, Grivennikov et al., 2010). 
Inflammatory/immune cells are a major source of tumor promoting cytokines. The role of the 
cytokines in tumor promotion is more firmly established by several lines of evidence. In lung 
cancer models of carcinogen-treated and K-ras mutation mice, chronic and subacute 
inflammation induced by CS promote tumor proliferation through release of inflammatory 
cytokines by myeloid cells (Takahashi et al., 2010). Lipopolysaccharide (LPS) induced acute 
inflammatory responses in macrophages favour lung metastasis growth of colon 
adenocarcinoma cells (Luo et al., 2004). In a model of CAC, inactivation of NF-B in 
myeloid cells decreased the production of inflammatory cytokines including IL-6, IL-11, 
TNF, IL-1, and IL-23, resulting in reduced tumor growth (Greten et al., 2004; Grivennikov 
et al., 2009; Grivennikov et al., 2010). In Mdr2-knockout mice, that develop cholestatic 
hepatitis followed by hepatocellular carcinoma, adjacent endothelial and inflammatory cells 
released TNF contributes to tumor promotion in HCC (Pikarsky et al., 2004). The 
mechanisms by which inflammation induces tumor promotion involve acceleration of cell 
cycle progression and cell proliferation, evasion from apoptotic cell death, and stimulation of 
tumor neovascularization (Kundu and Surh, 2008).  
Inflammatory mediators released by tumor infiltrating immune cells activate the oncogenic 
transcription factors NF-B and STAT3 in cancer cells and induce the expression of a variety 
of target genes important for cell proliferation and survival. This is a major tumor-promoting 
mechanism (Grivennikov et al., 2010; Yoshimura, 2006). The NF-B or STAT3 regulated 
target genes include proliferative genes (PCNA, Cyclins, c-Myc), anti-apoptotic genes (c-IAP, 
Bcl-xL, Bcl-2, c-FLIP), stress-response genes (SOD2, ferritin heavy chain, hsp70), 
chemokines, and pro-angiogenic molecules (VEGF, bFGF, CXCL12) (Luo et al., 2004; 
Grivennikov et al., 2010).  On the contrary, NF-B or STAT3 activation in immune cells 
controls the production of pro-inflammatory cytokines, including TNF, IL-1, IL-6, and IL-
23, which induce NF-B and STAT3 activation in malignant cells (Karin, et al., 2005; 
Grivennikov and Karin, 2010b). Recent reports showed that IL-6 produced by lamina propria 
myeloid cells enhanced proliferation of tumor initiating cells and protects premalignant 
intestinal epithelial cells from apoptosis through transcription factor STAT3 (Grivennikov, et 
al., 2009). In addition, NF-B and STAT3 also directly regulate the expression of some 
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important proangiogenic genes, such as IL-8, CXCL1, CXCL8, VEGF, and hypoxia-inducible 
factor1 alpha (HIF1) in inflammatory/immune cells (Rius et al., 2008; Kujawski et al., 2008).  
 
1.1.5 Inflammation and tumor progression 
It has been suggested that promotion of tumor progression is another important effect of 
inflammation. TAMs are an important partner for tumor cell progression. They produce 
colony stimulating factor 1(CSF1), IL-6, IL-1, and TNF resulting in tumor progression. Co-
culture with macrophages by transwell inserts leads to increased invasive capacity of the 
tumor cells in a TNF, NF-B, and matrix metalloprotease dependent manner (Hagemann et 
al., 2005). Studies with CSF1 deficient of breast cancer transgenic mice showed that the 
incidence or growth of the primary tumors is normal, however, the tumors are unable to 
develop invasive, metastatic pulmonary carcinomas, and this was associated with an impaired 
infiltration of macrophages into the primary tumor (Lin et al., 2001). 
Immune cells produced cytokines, chemokines, and proteases are generally considered to 
be responsible for tumor metastasis. For example, TGF, TNF, IL-6, and IL-1 regulate the 
process of epithelial to mesenchymal transition (EMT) which is crucial for tumor progression. 
EMT is mediated via the production of various EMT regulators, such as Snail, Twist, and 
Kiss in STAT3 and NF-B-mediated manner (Grivennikov et al., 2010; Yu et al., 2009). 
TNF can increase vascular permeability, augment expression of adhesion molecules on 
endothelial cells, and facilitates tumor cells migration (Grivennikov et al., 2006; Balkwill and 
Mantovani, 2001). MMPs, such as MMP9 and MMP2, are produced by inflammatory 
/immune cells and by stromal cells and degrade the extracellular matrix and facilitate invasion 
and extravasation of tumor cells (Grivennikov et al., 2010). Chemokines direct the movement 
of tumor cells towards blood vessels and inflammatory cytokines, such as TNF, IL-6, and 
IL-1 possibly increase this effect through up-regulation of chemokine-receptor expression in 
malignant cells (Mantovani et al., 2008). 
 
1.2 NF-B and the role in cancer 
NF-B was identified in 1986 as a nuclear factor bund to the kappa immunoglobulin gene 
enhancer in B cells (Aggarwal, 2004). However, NF-B has since been shown to be 
ubiquitously expressed in the cytoplasm of every cell type. NF-B is a key coordinator of 
inflammatory and immune response and has recently been found to play a pivotal role in 
carcinogenesis of a number of cancers (Karin, 2006). It is noteworthy that the pro-
inflammatory cytokines and chemokines mentioned above have been linked to carcinogenic 
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processes in humans and mice, and are regulated by the NF-B pathway. These pro-
inflammatory factors are mostly produced by inflammatory/immune cells, such as myeloid 
cells, and ultimately activate NF-B transcription factor. In myeloid cells, NF-B generally 
contributes to the expression of inflammatory mediators, cytokines, and growth factors. 
However, in tumor cells, NF-B influences tumor initiation, promotion, and progression. 
Therefore, NF-B has different roles in different cell types during tumor development.  
 
1.2.1 NF-B pathway 
NF-B is assembled by the dimerization of five homologous subunits: RelA (p65), c-Rel, 
RelB, NF-B1 (p50/p105), and NF-B2 (p52/p100) (Luo et al., 2005; Ghosh and Karin, 
2002). These members share a highly conserved Rel homology domain (RHD) which is 
responsible for DNA binding, dimerization, and interaction with the NF-B inhibitor B 
(IB) (Luo et al., 2005; Ghosh and Karin, 2002). A wide range of stimuli can activate NF-
B and more than 100 genes are induced on its activation. There are two distinct and 
evolutionarily conserved NF-B signalling pathways described (Fig. 2). The classical 
pathway is normally triggered by a variety of inflammatory stimuli including microbial 
stressors, viral infections, and cytokines, such as LPS, TNF, and IL-1 (Hoffmann and 
Baltimore, 2006). In resting stage of cell, most NF-B are retained in the cytoplasm by IB. 
On activation, cell stimulation results in activation of the three subunit IB kinase (IKK) 
complex consisting of two catalytic subunits (IKK and IKK) and a regulator component 
(IKK/NEMO). The activated IKK complex then phosphorylates IB followed by 
ubiquitination and eventual proteasomal degradation. The liberated NF-B dimers, mostly 
p50:RelA dimers, translocate to the nucleus where they modulate the transcriptional 
activation of several hundred target genes encoding cytokines, growth factors, cell adhesion 
molecules, and antiapoptotic proteins (Karin, 2006; Aggarwal, 2004; Yoshimura, 2006). The 
other pathway, the alternative pathway, is activated by B-cell-activating factor of TNF family, 
CD40, lymphotoxin-, LPS, and latent membrane protein (LMP)-1 of Epstein-Barr virus 
(EBV) via selective activation of IKK homodimers by the upstream kinase NIK (Perkins 
and Gilmore, 2006). Activation of IKK homodimers results in phosphorylation of p100/NF-
B2 protein, inducing its proteolytic processing to p52, then p52:RelB dimers enter the 
nucleus (Perkins and Gilmore, 2006; Hoffmann and Baltimore, 2006). The classical pathway 
is responsible for innate immunity and inflammation and the alternative pathway is mostly 
involved in the generation of secondary lymphoid organs and B-cell maturation and survival 
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(Karin, 2006; Karin and Lin, 2002). Although both pathways of NF-B have been implicated 
in tumor development, the classical pathway is likely more important for carcinogenesis 
(Karin and Greten, 2005; Naugler and Karin, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Two NF-B signalling  pathways. 
The classical pathway is normally triggered by a variety of inflammatory stimuli including microbial 
products, viral infections, and cytokines. The activated IKK complex phosphorylates IB followed by 
ubiquitination and eventual proteasomal degradation. The liberated NF-B dimers (p50:RelA dimmers) 
translocate to the  nucleus where they modulate the transcriptional activation of several hundred target genes 
encoding cytokines, growth factors, cell adhesion molecules and antiapoptotic proteins. The other pathway, 
the alternative pathway, is activated by B-cell-activating factor of TNF family, CD40, lymphotoxin-, LPS, 
and latent membrane protein (LMP)-1 of Epstein-Barr virus (EBV) via selective activation of IKK 
homodimers by the upstream kinase NIK. Activation of IKK homodimers results in phosphorylation of 
p100/ NF-B2 protein inducing its proteolytic processing to p52, then p52:RelB dimers enter the nucleus. 
The alternative pathway is involved in the generation of secondary lymphoid organs and B-cell maturation 
and survival. Bcl-2, B-cell lymphoma 2; BCL-xL, B-cell lymphoma xL; cFLIP, cellular caspase-8 (FLICE)-
like inhibitory protein; cIAPs, inhibitor of apoptosis protein; COX-2, cyclooxygenase-2; GM-CSF, 
granulocyte-macrophage colony stimulating factor; IB, inhibitor of B; IKK, IB kinase; IL-1, 
interleukin 1; IL-, interleukin 6; LPS, lipopolysaccharide; TNF, tumour necrosis factor  (adapted from 
Karin, 2006; Aggarwal, 2004; Yoshimura, 2006).  
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1.2.2 NF-B pathway and tumor development 
Constitutive activation of NF-B has been observed in most tumor cells, both solid and 
hematologic tumors, including lung cancer, breast cancer, colon cancer pancreatic cancer, and 
various types of leukaemia (Naugler and Karin, 2008). Inhibition of NF-B in these tumor 
cells results in abrogation of proliferation and in increased apoptosis indicating the crucial 
role of NF-B in cell proliferation and survival (Aggarwal, 2004). Furthermore, sustained NF-
B activation in tumor associated inflammatory cells including myeloid cells has been 
reported (Karin et al., 2006, Grivennikov and Karin, 2010a). Based on many functions of the 
classical NF-B pathway target genes, it has been proposed that the classical NF-B pathway 
has a crucial role in inflammation caused tumor promotion and progression (Karin and Greten, 
2005) (Fig. 3). It has been accepted that many pro-inflammatory cytokines produced by 
myeloid cells, such as TNF, IL-6, and IL-1, are growth factors of tumors and regulated by 
NF-B. On the contrary, these pro-inflammatory cytokines stimulate NF-B activation and 
induce transcription of NF-B target genes including cyclinD1, c-Myc, COX-2,  Bcl-XL, Bcl-
2, and XIAP in malignant cells, which regulate cell proliferation, survival, angiogenesis, 
invasion, and metastasis (Grivennikov and Karin, 2010a; Naugler and Karin, 2008; Aggarwal 
et al. 2009) (Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: NF-B activation has a crucial role in inflammation to tumour promotion and progression. 
Many pro-inflammatory cytokines and chemokines, such as TNF, IL-6, and IL-1, are growth and survival 
factors of tumors and are produced by myeloid cells and other inflammatory cells in a NF-B dependent 
manner. These pro-inflammatory cytokines and chemokines stimulate NF-B activation and induce 
transcription of NF-B target genes in cancer cells, which regulate cell proliferation, survival, angiogenesis, 
invasion, and metastasis. CSF1, colony stimulating factor 1; CXCL8, CXC-chemokine ligand 8, also known 
as IL-8; IL-1, interleukin 1; IL-, interleukin 6; MMPs, matrix metalloproteinases; TNF, tumour necrosis 
factor   VEGF, vascular endothelial growth factor (adapted from Karin and Greten, 2005). 
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Numerous lines of evidence demonstrate a role of NF-B in inflammation promoted tumor 
development. Karin’s group found that IKK ablation (leading to decreased NF-B activity) 
in myeloid cells reduces the CS induced inflammatory response in the lung and abrogates 
lung tumor development (Takahashi et al., 2010). In a metastatic colon cancer mouse model, 
LPS- induced expression of TNF in host cell (most likely macrophages) resulting in NF-B 
mediated growth of metastatic cancer in the lung, whereas abolished NF-B in colon cancer 
cells resulted in tumor regression by TNF-related-apoptosis-inducing-ligand (TRAIL), also 
known as Apo2 ligand, is a type II transmembrane protein of the TNF family (Luo et al, 
2004). In a mouse model of CAC, deletion of IKKin enterocytes and myeloid cells resulted 
in reduced tumor multiplicity and tumor size by different mechanisms. IKKdeficiency in 
enterocytes resulted in a 80% decrease in tumor multiplicity without affecting tumor size and 
Figure 4: Target genes of NF-B signalling pathway that mediate tumourigenesis. 
Bcl-2, B-cell lymphoma 5; BCL-xL, B-cell lymphoma xL; bFGF, basic fibroblast growth factor; cFLIP, 
cellular caspase-8 (FLICE)-like inhibitory protein; cIAP1/2, inhibitor of apoptosis protein 1/2; CXCR4, CXC 
chemokine receptor-4; ELAM-1, endothelial cell leukocyte adhesion molecule-1; HGF, hepatocyte growth 
factor; ICAM-1, intercellular adhesion molecule-1; MMP-9, matrix metalloproteinase-9; MnSOD, 
manganese superoxide dismutase; PDGF, platelet-derived growth factors; STAT3, signal transducer and 
activator of transcription 3; uPA, urokinase-type plasminogen activator; VCAM-1, vascular cell adhesion 
molecule-1; VEGF, vascular endothelial growth factor; XIAP, X-linked inhibitor of apoptosis protein 
(adapted from Grivennikov et al., 2010; Naugler and Karin, 2008; Aggarwal et al. 2009). 
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increased apoptosis of enterocytes, suggesting NF-B in enterocytes contributes to early 
stages tumor initiation and/or promotion (Greten et al., 2004). When IKKwas deleted in 
myeloid cells, tumor size was considerably smaller compared to controls and expression of 
pro-inflammatory cytokines, such as TNF, IL-6, and IL-1, was also markedly reduced 
(Greten et al., 2004). However, deletion IKKin myeloid cells had no effect on 
azoxymethane (AOM)-induced tumor apoptosis. Thus in myeloid cells, NF-B activation 
promotes tumor growth. This effect is mainly due to enhanced tumor cell proliferation via the 
production of TNF, IL-6, and other cytokines (Greten et al., 2004; Grivennikov and Karin, 
2010a). In a mouse model of diethylnitrosamine (DEN) induced hepatocellular carcinoma 
(HCC), deletion of the gene encoding IKKin hepatocytes resulted in a remarkable increase 
in the number of tumors as well as in tumor size, growth rate and aggressiveness. However, 
simultaneous deletion of IKKin both hepatocytes and Kupffer cells (liver macrophage) 
resulted in the reduction of number and size of HCC tumors. In this case, NF-B inactivation 
in hepatocytes increased DEN-induced cell apoptosis or necrosis and resulted in hepatocytes 
compensatory proliferation. Compensatory proliferation is mainly due to production of pro-
inflammatory cytokines (including TNF, IL-6) by NF-B activation in Kupffer cells that 
respond to necrotic hepatocyte, and ablation of IKKprevent induction of these cytokines 
after DEN administration resulting in a remarkable decrease in tumor load (Maeda et al., 2005; 
Naugler et al., 2007; Karin and Greten, 2005).  Additionally, Umar and colleagues found NF-
B mediated hyperproliferative effects of progastrin on proximal colonic crypts by enhanced 
Wnt/-catenin signaling (Umar et al., 2009). 
NF-B also regulates tumor metastasis and angiogenesis by modulating the transcription of 
relevant gene products (Aggarwal, 2004). For example, some critical proteases involved in 
tumor invasion and metastasis, such as MMP9, MMP2, and urokinase type of plasminogen 
activator (uPA), are regulated by NF-B (Aggarwal, 2004, Naugler and Karin, 2008). 
Metastasis requires various adhesion molecules including ICAM-1, VCAM-1, and ELAM-1, 
which are regulated by NF-B (Naugler and Karin, 2008). As described above, EMT is 
crucial for metastasis. In a breast cancer model, NF-B activation was implicated in EMT and 
its target genes included E-cadherin, Bcl2, MMP2/9, VCAM-1, and ELAM-1 were found 
responsible for this action (Chua et al., 2007, Wang et al., 2007, Naugler and Karin, 2008). 
TAMs promote tumor progression by increasing the formation of new blood vessels, which is 
dependent on NF-B signalling (Karin and Greten, 2005). In TAMs, the NF-B regulated 
inflammatory cytokines TNF, IL-6, and IL-1 can up-regulate COX2 expression by NF-B 
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activation. This leads to hypoxia-inducible factor 1  (HIF1) expression resulting in VEGF 
production (Jung et al., 2003). 
 
1.3 Wnt/-catenin pathway and cancer 
The Wnt family of proteins constitutes 19 secreted cysteine-rich glycoproteins that not only 
play a critical role in the embryonic development and maintenance of homeostasis in mature 
tissue but also in cellular proliferation, differentiation, motility, and survival and /or apoptosis. 
Wnt ligands bound to their receptor activate multiple signalling pathways including the 
canonical Wnt/-catenin pathway, the noncanonical planar cell polarity pathway, the 
Wnt/Ca
2+
 pathway, and the protein kinase A pathway (Takahashi-Yanaga and Kahn, 2010; 
Neumann et al., 2010). Of these four, the canonical Wnt/-catenin pathway is by far the best 
understood (Fig. 5). The activity of the Wnt/-catenin pathway is dependent on cytoplasmic 
-catenin protein. In the absence of Wnt signalling, cytoplasmic β-catenin is phosphorylated 
on several serine and threonine residues by the destruction complex containing glycogen 
synthase kinase-3 (GSK3), casein kinase1 (CK1), axin and adenomatous polyposis coli 
(APC). Phosphorylation leads to ubiquitin-proteasome-mediated degradation of β-catenin. 
Binding of Wnt ligands to Frizzled and to low-density lipoprotein receptor-related protein 
(LRP) receptors leads to activation of the phosphoprotein Dishevelled (Dsh or Dvl) and the 
inhibition of the destruction complex including Axin, GSK3, which reduces the 
phosphorylation and degradation of -catenin. Nonphosphorylated β-catenin translocates into 
the nucleus where it binds to T cell factor/lymphocyte enhancer factor (TCF/LEF) family 
transcription factors and modulates expression of a broad range of target genes, such as 
cyclinD1 and c-Myc (Moon et al., 2004; Reya and Clevers, 2005; Fodde and Brabletz, 2007). 
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The Wnt/-catenin signalling pathway is essential to lung morphogenesis. However, recent 
research showed that its activation is involved in the initiation and promotion phase of lung 
tumorigenesis (Moon et al., 2004; Konigshoff and Eickelberg, 2010). Although mutations in 
key Wnt signalling gene, such as -catenin or APC, are rare in lung cancer, activation of 
Wnt/-catenin signalling pathway has been found in various non-small cell lung cancer 
(NSCLC) cell lines and lung cancer (Licchesi et al., 2008; Retera et al., 1998). 
Overexpression of cyclinD1 and COX2 in lung adenocarcinomas suggests that the Wnt/-
catenin signalling pathway may be constitutively active (Licchesi et al., 2008). In NSCLC, 
overexpression of the intracellular signal transducer Dsh increased -catenin expression and 
promoted TCF-dependent transcriptional activity in Wnt/-catenin signalling pathway 
resulting in increased tumor cell growth (Uematsu et al., 2003; Konigshoff and Eickelberg, 
Figure 5: the canonical Wnt/-catenin pathway. 
In the absence of Wnt signalling, cytoplasmic β-catenin is phosphorylated on several serine and threonine 
residues by the destruction complex containing glycogen synthase kinase-3 (GSK3), casein kinase1 
(CK1), Axin and adenomatous polyposis coli (APC) leading to ubiquitin-proteasome-mediated degradation. 
Binding of Wnt ligands to Frizzled and low-density lipoprotein receptor-related protein (LRP) receptors leads 
to activation of the phosphoprotein Dishevelled (Dsh or Dvl), and the inhibition of destruction complex 
including Axin, GSK3, which reduces the phosphorylation and degradation of -catenin. 
Nonphosphorylated β-catenin translocates into the nucleus where it binds to T cell factor/lymphocyte 
enhancer factor (TCF/LEF) family transcription factors and modulate expression of a broad range of Wnt 
target genes (adapted from Moon et al., 2004; Reya and Clevers, 2005; Fodde and Brabletz, 2007). 
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2010). Hommura and colleagues examined specimens of 217 surgically resected primary 
NSCLC and found that increased -catenin expression is associated with enhanced cell 
proliferation and a better prognosis (Hommura et al., 2002). Activation of Wnt/-catenin 
signalling is also found in colon cancer, gastric cancer, skin cancer, and breast cancer, and 
Wnt activation has been demonstrated to be a major cause for the development of these 
cancers (Oguma et al., 2008; Fodde and Brabletz, 2007; Clevers, 2006). Although the 
constitutive activation of the Wnt/-catenin pathway by mutations in APC or the -catenin 
gene contributes to many tumors tumorigenesis, accumulating evidences suggests that further 
promotion of the Wnt/-catenin pathway activity has an important function in tumor growth 
and progression (Fodde and Brabletz, 2007; Oguma et al., 2008). For example, increased 
nuclear entry of -catenin in colon and gastric cancer cells promotes tumor cell growth 
(Castellone et al., 2005; Oguma et al., 2008). Moreover, in the invasive front of colon cancer, 
increased nuclear -catenin accumulation is also observed (Brabletz et al., 1998). 
Wnt/-catenin pathway activation has been implicated in inflammation associated cancer. 
It has been reported that macrophages increase Wnt/-catenin signalling activity in 
gastrointestinal tumor cells through production of some inflammatory cytokines such as 
TNF and IL-1which contributes to tumors growth (Oguma et al., 2008; Kaler et al., 2009). 
For example, in gastric tumor cells, macrophage-derived TNF promotes Wnt/-catenin 
signalling through inhibition of GSK3, whereas in colon cancer cells, macrophage-derived 
IL-1 acts same function (Oguma et al., 2008; Kaler et al., 2009). Castellone et al. also 
provided evidence that inflammation directly influences the mutationally activated Wnt/-
catenin signalling, which is responsible for growth of colorectal cancer (Castellone et al., 
2005). They found that inflammatory prostaglandin E2 stimulates colon cancer cell growth 
through enhanced accumulation of -catenin in the nucleus. This resulted in enhanced 
activation of Wnt/-catenin signalling, already activated to some degree in these cells (owing 
to the mutant APC gene) (Castellone et al., 2005). Although the mechanistic details of above 
reports remain to be addressed, a clear link among inflammation, Wnt/-catenin signalling 
and growth of tumor cells is established. 
 
1.4 Antimicrobial peptides (AMPs) 
Antimicrobial peptides (AMPs) are key effectors of the innate immune system with direct 
antimicrobial function. AMPs further act as inflammatory mediators and modulate processes 
such as wound repair, cell proliferation, and angiogenesis (Zasloff, 2002; Wah et al., 2006). 
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According to size, tertiary structure or predominant amino acids sequence, there are two main 
families of AMPs in human and other mammals: the defensins and the cathelicidins. They are 
expressed in immune cells and at epithelial surfaces (Chromek et al., 2006; Herr et al., 2007). 
 
1.4.1 Defensins 
Defensins are a family of cysteine-rich, cationic peptides, which includes two major 
subgroups: -defensins and -defensins, classified by the pattern of disulfide bonding and 
each subfamily consist of several members (Coffelt and Scandurro, 2008). -defensins 1-4 are 
located in neutrophil primary (azurophilic) granules and are also called human neutrophil 
peptides (HNP1-4). Human -defensin 5 (HD5) and 6 (HD6) are primarily secreted from 
Paneth cells of the small intestine (Herr et al., 2007). Generally, -defensins are expressed by 
epithelial cells, macrophages and lymphocytes, and consists of a variety of members, such as 
human -defensin1 (hBD-1), human -defensin 2 (hBD-2), human -defensin3 (hBD-3), and 
human -defensin4 (hBD-4) (Beisswenger et al., 2005). Moreover up to 28 new human and 
43 new mouse -defensin genes in 5 syntenic chromosomal regions have been identified by 
computer-based screening of the human and murine genomes (Beisswenger et al., 2005).  
The expression of defensins in the lung can be induced by pro-inflammatory stimuli or 
microorganisms. They directly kill microbes and disrupt their cell membranes, resulting in 
increased permeability and leakage of small molecules (Herr et al., 2007). Additionally, 
defensins also have other biological functions. For example, in bronchial epithelial cells, -
defensins-induced IL-8 increases inflammatory reaction and subsequent recruitment of 
neutrophils (Van et al., 2002). Moreover, -defensins bind to protease inhibitors such as 1-
antitrypsin, and inactivate their antiprotease activity, which increase inflammation (Panyutich 
et al., 1995). Furthermore, defensins also are chemoattractants for leukocytes and other 
immune cells (Herr et al., 2007). Several evidences display that the defensins involve in 
cancer process, and have different effects to tumor development.  In prostate cancer and renal 
clear cell carcinoma samples, the expression of hBD-1 almost is suppressed, but followed by 
reintroduction of hBD-1 to prostate and renal cancer cells lines, proliferation is inhibited and 
apoptosis is induced (Sun et al., 2006; Bullard et al., 2008). However, a study found that 
murine -defensin 29 (mBD-29), the homologue of human hBD-2, has a proangiogenic, 
protumorigenic founction (Conejo-Garcia et al., 2004).  This study suggest mBD-29 and 
vascular endothelial growth factor-A (Vegf-A) cooperate to promote mouse ovarian tumor 
growth by accumulation of dendritic cell precursors (Conejo-Garcia et al., 2004).  
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1.4.2 Cathelicidin 
Human cathelicidin antimicrobial protein LL-37/hCAP18 is the only known cathelicidin in 
man (Beisswenger et al., 2005). LL-37/hCAP18 is constitutively produced by professional 
host defense cells, such as macrophages or neutrophils, by epithelial cells of the skin, 
gastrointestinal tract and urinary tract, by the epididymis and by respiratory epithelial cells 
(Shaykhiev et al., 2005; Chromek et al., 2006). hCAP18 consists of 3 domains: the N-terminal 
signal peptide, the highly conserved cathelin-like domain and the C-terminal peptide termed 
LL-37 peptide (Coffelt and Scandurro, 2008). LL-37 peptide is maintained in its pro-peptide 
form until secretion after cleavage by protease 3 (Coffelt et al., 2008; Beisswenger et al., 
2005). In mice, the gene encoding for cathelicidin is called Cnlp. Cnlp is very similar to the 
human gene. The mouse cathelicidin is termed cathelicidin related antimicrobial peptide 
(CRAMP) showing several close similarities to human LL-37 including an -helical structure, 
antimicrobial function, and analogous tissue distribution (Kurosaka et al., 2005; Chromek et 
al., 2006; Koczulla et al., 2003).  
A variety of stimuli found in infection and inflammation, such as pro-inflammatory 
cytokines, growth factors, nutrients, and bacterial products, as well as injury can up-regulated 
expression of LL-37/hCAP18 (Bucki et al., 2010). It has been shown that the expression of 
LL-37/hCAP18 is increased in the airways of patients with inflammatory and infectious lung 
diseases (Shaykhiev et al., 2005). In human myeloid cells, 1,25-dihydroxyvitamin D3 strongly 
stimulates the expression of LL-37/hCAP18 gene via the vitamin D receptor (Gombart et al., 
2005; Liu et al., 2006). However, induction of CRAMP in murine cells has not been observed 
as there is no vitamin D response element (VDRE) in the CRAMP gene promoter (Gombart et 
al., 2005). Liu et al., reported that Toll-like receptor activation of human macrophages results 
in up-regulated expression of the vitamin D receptor and 25-hydroxyvitamin D-1-a-
hydroxylase (CYP27B1). This led to the induction of LL-37/hCAP18 and killing of 
intracellular mycobacterium tuberculosis (Liu et al., 2006). The NF-B signalling pathway 
also plays an important role in the regulation of cathelicidin.  Inhibition of NF-B by siRNA 
or over-expression of IB reduced both basal and induced levels of CRAMP mRNA in 
murine mast cells (Li et al., 2009). In macrophages, activation of NF-B is also important for 
LL-37-mediated cytokine release (Mookherjee et al., 2009). HIF1 is also involved in up-
regulation of LL-37/hCAP18 in myeloid cells and keratinocytes (Peyssonnaux et al., 2008). 
Beyond its activity against microorganisms, LL-37/hCAP18 is involved in various 
processes in different immune reactions, including immune modulation, inflammatory 
reaction, cell proliferation, angiogenis, and antiapoptosis (Bucki et al., 2010). In various 
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inflammatory lung diseases, LL-37 is a regulator of immune responses by stimulation of IL-8 
production in human airway smooth muscle cells (Zuyderduyn et al., 2006). In human 
bronchial epithelial cells, LL-37 enhances cellular activation by LPS resulting in increased 
release of the inflammatory cytokines IL-6 and IL-8 (Shaykhiev et al., 2010). LL-37 can bind 
to formyl peptide receptor-like 1 (FPRL1), a promiscuous receptor expressed on a variety of 
cells including neutrophils, monocytes, and lymphocytes, and attracts neutrophils, monocytes 
and CD4
+
 T cells, and activates mast cells (Herr et al., 2007). Moreover, LL-37 induces 
wound healing, cell proliferation, and migration of airway epithelial cells, suggesting that this 
peptide is likely involved in the regulation of tissue homeostasis in the airways (Shaykhiev et 
al., 2005). Deficiency of CRAMP in mice resulted indecreased vascularization during wound 
repair indicating important action of cathelicidins during angiogenesis (Koczulla et al., 2003). 
A growing body of evidence indicates that LL-37/hCAP18 is related to tumorigenesis in 
prostate, breast, ovarian, and lung cancers (Bucki et al., 2010, Hensel et al., 2010). For 
example, LL-37 is strongly expressed in human lung cancer and treatment with synthetic 
biologically active LL-37 peptide or transgenic expression LL-37 shows a significant increase 
in the proliferation of lung tumor cells. This research suggests that LL-37acts as growth factor 
for human lung cancer (Von Haussen et al., 2008). The pro-inflammatory peptide LL-37 also 
contribute to ovarian proliferation, invasion, and progression through direct stimulation of 
tumor cells, initiation of angiogenesis and recruitment of immune cells (Coffelt et al., 2008; 
Coffelt et al., 2009). Additionally, LL-37 also strongly expressed in breast cancer and it is 
considered to be a growth factor for epithelial cells (Heilborn et al., 2005).  A recent report 
showed that CRAMP knock-down in a murine prostate cancer model results in decreased 
proliferation and invasion of tumors, which involved Erk1/2 and Akt singnalling (Hensel et 
al., 2010). Accordingly, these findings support the hypothesis that LL-37 is a growth factor of 
tumor cell.   
 
1.5 Cigarette smoke and lung cancer 
Lung cancer is the most common cause of cancer mortality in the world, causing more than 
one million deaths worldwide (Walser et al., 2008). In the European Union (EU), lung cancer 
accounts for more than 25% or 12% of total cancer deaths in men or women, respectively 
(Malvezzi et al., 2011). Although lung cancer death rates have a decliny trend in men since 
the late 1980s in the EU, lung cancer mortality in women has increased up to 2007, and the 
upward trend is likely to continue until 2011(Levi et al., 2004; Malvezzi et al., 2011). Lung 
cancer is divided into two broad categories: Small cell lung carcinoma (SCLC) and non-small 
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cell lung cancer (NSCLC) (Webb et al., 2010, Sun et al., 2007). SCLC is the less common 
form of lung cancer, making up approximately 15% of lung cancer cases, which has 
neuroendocrine characteristics and are a highly malignant tumor type (Webb et al., 2010). 
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases and are 
further classified into three major types: adenocarcinoma, squamous cell carcinoma, and large 
cell carcinoma (Herbst et al., 2008). Among lung cancers, pulmonary adenocarcinoma is the 
predominant histological type and represents approximately 31% of lung cancers 
(Beadsmoore et al., 2003). 
Cigarette smoke (CS) is the most important risk factor for lung cancer, which is associated 
with almost 90% of case in men and 70 to 80% of case in women (Jemal et al., 2003; Walser 
et al., 2008). Clinical studies have shown that smokers have as much as 30-fold increased risk 
of developing cancer relative to nonsmokers (Walser et al., 2008), and even after smoking 
cessation, the relative risk never returns to that of a non-smoker during the first 5 years (Hecht 
et al., 1999). Multifocal premalignant lesions have been found in bronchial tree of smokers 
and as in lung cancer patients, bronchial epithelium of smokers displays multistage foci of 
genetic changes which contribute to lung cancer risk (Wistuba et al., 1997, Yashima et al., 
1997). Furthermore, by high-density gene expression arrays analysis, gene changes have been 
found even in histological normal airway epithelial cells of smokers (Spira et al., 2004, Spira 
et al., 2007). Tumor-promoting effect of CS exposure has been identified in a mice model of 
Lewis lung cancer and chemically or genetically initiated lung cancers (Zhu et al., 2003, 
Takahashi et al., 2010). CS has been also found to activate prometastatic oncogene synuclein-
 (SNCG) and may contribute to lung cancer progression (Liu et al., 2007). CS is a complex 
mixture and contains over 4000 identified chemical agents including over 60 carcinogens: 
polycyclic aromatic hydrocarbons (PAHs), N-nitrosamines and aromatic amines are the 
strongest carcinogens (Dasgupta et al., 2009; Takahashi et al., 2010; Hecht et al., 2002). For 
example, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N’-nitrosonornicotine 
(NNN) are known to form DNA adducts that mutate vital growth regulatory genes like p53 
and Ras, initiate lung cancer (Dasgupta et al., 2009,  Hecht et al., 2002). In addition, nicotin 
which is a major component of CS has been shown to promote angiogenesis and to accelerate 
tumor growth and atherosclerosis (Zhu et al., 2003, Villablanca et al., 1998, Dasgupta et al., 
2006). Moreover, Dasgupta and colleagues found that nicotine induces cell proliferation, 
invasion and EMT mediated by the nicotinic acetylcholine receptors (nAChRs) and that it 
inhibits apoptosis induced by chemotherapeutic drugs by up-regulation XIAP and survivin 
proteins expression in lung cancer cells (Dasgupta et al., 2006, Dasgupta et al., 2009).  
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It is understood that CS exposure increases the pulmonary inflammatory response. Long 
time or short time CS exposure of mice increases recruitment of inflammatory cells 
(macrophages, neutrophils, lymphocytes and dendritic cells), activates the NF-B pathway 
and induces production of inflammatory mediators (TNF, IL-6, IL-8) (D'hulst et al., 2005; 
Vlahos et al., 2006; Takahashi et al., 2010). Some evidences indicated that chronic and 
subacute inflammation induced by CS is also clearly linked to cancer development 
(Yoshimura, et al., 2006; Takahashi et al., 2010). Chronic obstructive pulmonary disease 
(COPD) which is characterized by abnormal inflammatory features in the lung and 
systemically is mostly caused by cigarette smoke and is associated with the greatest risk for 
lung cancer (Walser et al., 2008, Yang et al., 2008; Punturieri et al., 2009). From clinical 
investigation it is known that the presence of COPD in smokers is associates with a 1.3 to 4.9 
fold increased risk of lung cancer compared to smokers without COPD (Moghaddam et al., 
2008). Moghaddam and coworkers used products of nontypeable Haemophilus influenzae 
which colonizes the airway of patients with COPD to demonstrate that COPD-like airway 
inflammation promotes lung carcinogenesis in a background of a G12D-activated K-ras allele 
in airway secretory cells (Moghaddam et al., 2008). Subacute exposure to second hand smoke 
promotes tumor angiogenesis and growth in a murine model of Lewis lung cancer which is 
associated with increased plasma levels of angiogenic cytokines including VEGF and 
monocyte chemoattractant protein-1 (MCP-1) as well as circulating endothelial progenitor 
cells (Zhu et al., 2003). Takahashi et al. found that CS induced chronic and subacute 
inflammatory responses increase the proliferation of lung tumor cells and alveolar epithelial 
cells in the lungs of mice (Takahashi et al. 2010). 
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2 Materials and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals and reagents 
 
-Mercaptoethanol     Roth, Karlsruhe, Germany 
Polyacrylamide gels (37.5:1)    Roth, Karlsruhe, Germany 
APS       Sigma, Steinheim, Germany 
Bromophenol blue     Fluka, Buchs (CH) , Germany 
BSA       Calbiochem, Darmstadt, Germany  
Glycerin      Roth, Karlsruhe, Germany 
Glycin       Roth, Karlsruhe, Germany 
H2SO4       Roth, Karlsruhe, Germany 
HCl       Roth, Karlsruhe, Germany 
Methanol      Center of chemical storage,  
       University of Saarland   
NaCl       Roth, Karlsruhe, Germany 
NaH2PO4. H2O     Merck, Darmstadt, Germany  
Na2HPO4      Fluka, Buchs (CH), Germany 
NaOH       AppliChem, Darmstadt, Germany 
Paraformaldehyde     Roth, Karlsruhe, Germany  
Protein Standard (SeeBlue® Plus2)   Invitrogen, Carlsbad, CA, USA 
Skim milk      Roth, Karlsruhe, Germany 
SDS       Roth, Karlsruhe, Germany 
TEMED      Sigma, Steinheim, Germany 
Tris base      Sigma, St. Louis, MO,USA 
Tween® 20      AppliChem, Darmstadt, Germany 
Citric acid monohydrate    Roth, Karlsruhe, Germany 
Ethanol      Roth, Karlsruhe, Germany 
Recombinant human TNF    Invitrogen,San Diego, CA, USA 
Recombinant human IL-1    eBioscience,San Diego, CA, USA
Recombinant human IFN    eBioscience,San Diego, CA, USA
Recombinant human biglycan   R&D systems, Minneapolis, MN, USA
Recombinant human EGF    Sigma, Steinheim, Germany 
Bay 11-7085      Sigma, Steinheim, Germany 
                                                                                                               Materials and Methods 
 24 
6-Amino-4-(4-phenoxyphenylethylamino)  
Quinazoline      Merck, Darmstadt, Germany 
Pyrrolidine dithiocarbamate    Sigma, Steinheim, Germany   
Pam2CSK4      Invivogen, San Diego, CA, USA
1,25(OH)2D3      Calbiochem, Darmstadt, Germany
                                                                                
 
2.1.2 Buffer 
 
 10×TBS buffer:   Tris base  24.2g 
NaCl   80g 
       Water   1000ml 
       Adjust pH to 7.6 
 
 TBS-T buffer:    TBS containing 0.1% Tween-20 
 
 SDS-polyacrylamide gels:  
 
Running Gel Solution 
 
Concentration 
(%) 
Total volume 
(ml) 
Distilled water 
(ml) 
30%Polyacrylamide 
(ml) 
1.5M Tris-HCl, 
pH 8.8 (ml) 
10% SDS 
(l) 
10%APS 
(l) 
TEMED 
(l) 
10 10 4 3.3 2.5 100 100 5 
12 10 3.3 4 2.5 100 100 5 
 
Stacking Gel Solution 
 
Concentration 
(%) 
Total volume 
(ml) 
Distilled water 
(ml) 
30%Polyacrylamide 
(ml) 
1M Tris-HCl, 
pH 6.8 (ml) 
10% SDS 
(l) 
10%APS 
(l) 
TEMED 
(l) 
5 5 3.4 0.83 0.63 50 50 5 
 
 
 
 
 2× Loading buffer:   100mM Tris-HCl, pH 6.8  
                                                        4% SDS  
                                                       0.2% bromophenol blue 
                                                        20% glycerine  
                                                        5% -mercaptoethanol 
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 5×SDS-PAGE running buffer: Tris base  15.1g 
                                                              Glycin                 94.0g 
                                                              SDS                      5g 
                                                               Water                    1000ml 
 
 SDS-PAGE transfer buffer:  Tris base         5.8g 
                                                          Glycin              2.9g 
                                                            SDS                 0.37g 
                                                             Methanol        200ml  
                                                              Water           1000ml  
 
 5% Skim milk   Skim milk        5g 
                                            TBS              100ml 
 
 10x Citrate buffer Citric acid monohydrate, pH 6.0    21g 
                      Water                                       1000ml 
 
 4 % Paraformaldehyde fixative (0.1 M. Sodium Phosphate Buffer, pH 7.2): 
       0.2M sodium phosphate buffer, pH 7.2:       Sodium phosphate monobasic     3.17g                                           
                                                                             (NaH2PO4.H20, FW 137.99) 
                                                                             Sodium phosphate dibasic  10.93g 
                                                                             (Na2HPO4, FW 141.96) 
                                                                             Water                                       500ml 
 
      8% Paraformaldehyde solution:                     Paraformaldehyde             40 g  
                                                                             Water                                500ml 
 
Heat the paraformaldehyde solution to 60 - 65°C while stirring. Reduce heat and add 2 to 3 
ml of 1.0 M NaOH, dropwise. After the solution has cleared, filter and add an equal volume 
of 0.2 M phosphate buffer. This fix is best used fresh and should be used within 72 h. 
 
 2% BSA            BSA                                       2g 
                                                                               TBS-T                             100ml 
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2.2 Methods 
 
2.2.1 Cell culture 
The human lung adenocarcinoma cell line A549 cells, mouse Lewis lung carcinoma (LLC) 
cells, human monocytic cell line U937 cells, and mouse macrophage cell line RAW264.7 
cells were cultured in Dulbeccos’s modified Eagles medium (DMEM) (Invitrogen, Grand 
Island, NY, USA). The medium was supplemented with 10% fetal calf serum (FCS) 
(Invitrogen, Grand Island, NY, USA), 100 U/mL penicillin and 100U/mL streptomycin (PAA 
Laboratories GmbH, Pasching, Austria). Cell culture was performed at 37°C in humidified air 
with 5% CO2. 
  
2.2.2 Generation of human peripheral blood monocyte-derived macrophages 
Buffy coats of healthy donors were obtained from the blood bank of the University hospital of 
Marburg. Buffy coats (about 7.5 ml) were diluted 1:2 with PBS (PAA Laboratories GmbH, 
Pasching, Austrlia). The diluted blood was gently overlaid on top of a 20 ml Ficoll-Paque (GE 
Healthcare, Uppsala, Sweden) in a 50 ml conical tube and centrifuged at 500 g for 30 min. at 
room temperature (RT) and stopped without braking. The layer containing white blood cells 
was recovered and transfered to a new 50 ml conical tube. 40 ml PBS were added and the 
cells were centrifuged at 400 g for 10 minutes at RT. The supernatant was discarded and 10 
ml RBC lysis buffer were added (155 mM NH4Cl; 10 mM KHCO3; 0.1 mM Na2EDTA; 
sterile filtered) to the pellet. The pellet was completely resuspended and incubated for 5 
minutes at RT and occasionally mixed gently. 30 ml PBS were added and the cells were 
centrifuged at 200 g for 5 minutes at RT. The supernatant was discarded and the pellet was 
washed with 40 ml PBS followed by centrifugation at 200 g for 5 minutes at RT. The 
supernatant was discarded and the cells were resuspended in 30 ml DMEM + 1% 
heatinactivated human serum. The sample was divided in 1 ×106 ml to 75 cm2 tissue culture 
flasks. Cells were allowed to adhere to culture flasks for 1 h at 37°C, 5% CO2 and non-
adherent cells were removed by vigorous washing 2-3 times with warm PBS. Adherent cells 
were cultured in 20 ml DMEM (10% FCS) supplemented with 50 ng/ml macrophage colony 
stimulating factor (M-CSF) (eBioscience, San Diego, CA, USA) for 7 days to allow 
differentiation to macrophages. 
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2.2.3 Monocytic differentiation 
U937 cells were treated with 10nM phorbol-12myristat-13acetat (PMA) (Sigma Aldrich, 
Steinheim, Germany) for 48 hour resulting in adherence of the cells to culture flasks. After 48 
hours, cells were washed and cultured for additional 24 hours in PMA-free DMEM (10% FCS) 
in order to reduce possible effects of residual PMA. Cells were detached by incubation with 
0.05% (v/v) trypsin-EDTA (Invitrogen, Grand Island, NY, USA) for 5 mins. Cells were 
enumerated by using a hemocytometer (Innovatis AG, Reutlingen, Germany) and seeded in 
multi-well cell culture plate in indicated number for further experiment. 
 
2.2.4 Cell transduction  
For establishing cell lines with stable knock down of RelA/p65, the pSuppressorNeo 
(Imgenex, San Diego, CA, USA) RNA interference (RNAi) plasmids RelA were constructed 
according to the protocols previously described (Takada et al., 2003). siRNA sequences for 
RelA gene were:CCCCTTCCAAGTTCCTATA and TATAGGAACTTGGAAGGGG. siRNA 
sequences of mock RNAi plasmids: GCGCGCTTTGTAGGATTCG and CGAATCCTACA 
AAGCGC GC. 
Log growth U937 cells were washed 1 time with PBS and resuspended at 2×10
7
 cells/ml in 
1 ml of Gene Pulser electroporation buffer reagent (Bio-Rad, Hercules, CA, USA), mixed 
with 20 g of RelA RNAi plasmids or mock RNAi plasmids. Electroporations were 
performed using a Gene-Pulser (Bio-Rad, Hercules, CA, USA) at 280V and 960 F in 0.4 cm 
cuvette (Bio-Rad, Hercules, CA, USA). The samples were transferred to culture flasks 
containing complete DMEM medium with10% FCS in 25 cm
2
 and incubated at 37°C in 5% 
CO2. 48 hours later, the growth medium was changed and G418 (PAA Laboratories GmbH, 
Pasching, Austria) was added at a concentration of 800 g/ml. The culture medium was 
changed every 4 days using fresh growth medium (containing 800g/ml G418). After 4 weeks, 
positive polyclonal populations (pools) were identified based on western blot analysis for p65 
expression. Individual positive clones were eventually isolated by limiting dilution analysis in 
96-well plates.  
 
2.2.5 Preparation of cigarette smoke extracts (CSE) 
CSE was prepared by bubbling smoke from 2 3R4F reference cigarette into 20 ml of serum-
free DMEM at a rate of 1 cigarette/min. This medium (defined as 100%) was adjusted to pH 
7.4, and was sterile filtered with a 0.2 m filter. CSE stock solutions were frozen in aliquots 
at -80°C. 
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2.2.6 Co-culturing lung cancer cells and macrophages  
Cells were rendered quiescent by serum starvation for 24 h. For co-culture studies with A549 
cells and macrophages (human primary macrophage or PMA-U937 cells), macrophages were 
seeded into the bottom of mutil-well cell culture plates and A549 cells were placed in 
transwell inserts (0.4 um, 6 wells from Dickinson and Company, Franklin Lakes, NJ, USA or 
12 or 24wells from Corning Incorporated, Corning, NY, USA) with a membrane permeable 
for liquids but not for cells. Cells were incubated overnight. The transwells were inserted into 
the well of mutil-well culture plate and cultured for indicated time. For CSE stimulation, co-
cultures, macrophages, and A549 cells were stimulated with indicated concentration of CSE. 
For inhibition of the NF-B pathway, the NF-B inhibitors Bay 11-7085, QNZ and PDTC 
were added at various concentrations as indicated 1-2 hours before co-culture and/or CSE 
stimulation. For TNF neutralization, neutralizing antibody (Clone # 6401, R&D Systems, 
Minneapolis, MN, USA) was added at 10 µg/ml. 
 
2.2.7 Cell proliferation assays 
2.2.7.1 Cell number count 
Cells were rendered quiescent by serum starvation for 24 h. Human primary macrophages 
(4×10
4
 cells) and A549 cells (2×10
4
 cells) were seeded in 12-well trans-well or cell culture 
plates and incubated overnight. Cells were co-cultured and treated with 0, 0.1, 0.25, and 0.5% 
CSE for 5 days. A549 cells were harvested after 5 days by trypsinization and counted with a 
hemocytometer (Innovatis AG, Reutlingen, Germany). 
 
2.2.7.2 CFSE cell proliferation assay 
Carboxyfluorescein diacetate, succinimidyl ester (CFSE) is a fluorescent cell staining dye. It 
diffuses freely inside the cells and intracellular esterases cleave the acetate groups converting 
it to a fluorescent, membrane impermeable dye. The label is inherited by daughter cells after 
cell division or cell fusion, but is not transferred to adjacent cells. CFSE is retained by the cell 
in the cytoplasm and does not adversely affect cellular function. During each round of cell 
division, relative fluorescence intensity of the dye is decreased by half. CellTrace™ CFSE 
Cell Proliferation Kit (Invitrogen, Eugene, OR, USA) was used in this experiment. A549 cells 
were digested by incubation with 0.05% (v/v) trypsin-EDTA for 5 mins. Cells were washed 3 
times with PBS and resuspend in prewarmed PBS/0.1%BSA at a final concentration of 1×10
6
 
cells/ml. CFSE solution stock was added (CFSE dissolved in DMSO) to the cell suspension 
for a final working concentration of 5 M. Cell were incubated at 37°C for 15 min. To stop 
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staining, 5 volumes of ice cold medium containing 10% FCS was added and the cells were 
incubated 5 min on ice. The cells were centrifugation and washed 3 times with fresh media. 
CFSE stained A549 cells were seeded in 12-well cell culture plate (2×10
4
 cells) and incubated 
overnight. Co-cultured of CFSE stained A549 cells and primary human macrophages (4×10
4
 
cells) were stimulated with or without CSE for 5 days in DMEM with 5% FBS. A549 cells 
were harvested at day 5 by trypsinization. Cells were washed 3 times in PBS and CFSE 
fluorescence was monitored by FACS (BD FACS Calibur, BD Biosciences, San Jose, CA, 
USA) and data analysis was performed using the BD CellQuest Pro software.  
 
2.2.7.3 BrdU ELISA cell proliferation assay 
A549 cell proliferation was determined by using the commercially available Cell Proliferation 
ELISA, BrdU (colorimetric) Kit (Roche, Mannheim, Germany). Co-cultured A549 cells 
(1×10
4
 cells) and primary human macrophages (2×10
4
 cells) were stimulated with or without 
CSE for 5 days in 24 well plates. At day 5, supernatants of A549 cells were aspirated and 400 
l/well growth media containing 10M BrdU was added. Cells were incubated for additional 
2 h at 37°C. Labelling medium was removed by tapping off and the cells were fixed by 
adding 500 l FixDenat. FixDenat solution was thoroughly removed by tapping. 400l/well 
anti-BrdU-POD working solution was added and cells were incubated for 90 min at RT. The 
antibody conjugate was removed by flicking off and wells were washed 3 times with PBS. 
After that, 400 l/well of a substrate solution were added and the solution was incubated at 
RT for 5-30 min. 400l 3N H2SO4 was added to each well and  the plates were incubated for 
1 min on the shaker. The absorbance was measured using ELISA reader at 450nm. 
 
2.2.8 Animal experiments 
CRAMP
-/-
 mice were kindly provided by Prof. Richard L. Gallo (Nizet et al., 2001). rela
F/F 
LysMCre (rela
Δ-/-
) mice with myeloid specific truncated RelA/p65 (deletion of exons 7-10 of 
the rela gene) have been described previously ( Hess et al.,2010; Algul et al., 2007; Clausen 
et al., 1999). Briefly, to generate a constitutive knockout of RelA/p65 in myeloid cells, rela
F/F
 
mice were crossed with LysMCre animals to generate a rela
F/F
 LysMCre mouse line. rela
wt/wt
 
LysMCre (WT) mice were used as control mice. All strains used in tumor studies had a 
C57BL6 background. Mice were maintained under a pathogen-free condition, and all animal 
experiments were approved by the Landesamt für Soziales, Gesundheit und 
Verbraucherschutz of the State of Saarland following the national guidelines for animal 
treatment.  
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2.2.9 Generation of lung cancer metastasis model in mice 
A lung cancer metastasis model in mice was generated by intravenous injection of LLC cells. 
LLC cells were derived from mouse Lewis lung carcinoma. Briefly, subconfluent LLC cells 
were harvested and passed through a 40μm cell strainer (BD Biosciences, Bedford, MA, 
USA), washed three times with PBS, resuspended in serum free DMEM and injected at a 
concentration of  2×10
5
 or 5×10
5
 cells per mouse into the tail vein. 
 
2.2.10 Cigarette smoke exposure 
Mice were placed in plexiglas smoke box and exposed to mainstream cigarette smoke (MCS) 
generated by burning 3R4F reference cigarettes (College of Agriculture, Reference Cigarette 
Program, University of Kentucky, Lexington, Kentucky, USA) using a smoking machine 
(Ugo Basile 7025 rodent ventilator, Comerio VA, Italy). Cigarette smoke was generated in 
270 ml/minute and diluted with fresh air (1800 ml/minute), and directed into a plexiglas 
smoke box. The average total suspended particulate (TSP) matter in the chamber 
approximately was 400-425 mg/m3. Mice were exposed to CS for 20 minutes 5 times per day 
for 7 days, followed by 7 days rest. Control groups were incubated with filtered air. For 
examining CS induced subacute inflammation and tumor cell proliferation in lungs, 7 days 
after intravenous injection of LLC cells, mice were exposed to CS for 7 consecutive days, 24h 
after the last CS exposure, mice were sacrificed and lungs were removed. For the lung tumor 
promotion study, mice were killed after 7 days rest interval and lungs were removed, weighed 
and histologically examined. Some mice were kept until 8 weeks and survival data were 
obtained. Lung tumor nodules were carefully microdissected from lungs using an 18G needle 
under a microscope. The entire tumor-bearing lung was used for ELISA and RNA analysis. 
The smoke exposure protocol is graphically displayed in Figure 11B. 
 
2.2.11 Bronchoalveolar lavage  
Bronchoalveolar lavage fluid (BALF) was determined as described previously (Hess et al., 
2010). In brief, lungs from mice were instilled with 3×1ml sterile PBS through the trachea. 
3ml of BALF were collected from each mouse. Cytospin preparations of BALF cells were 
prepared with 200l volume at 500 rpm for 5 min on cytospin centrifuge (Tharmac, 
Waldsolms, Germany). BALF cells were stained with DiffQuik (Medion Diagnostics AG, 
Düdingen, Switzerland) and percentages of leukocyte types were determined by light 
microscopy. The total number of leukocyte in the BALF was determined by using a 
hemocytometer (Innovatis AG, Reutlingen, Germany). Alveolar macrophages were isolated 
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for western blot as previously described (Vlahos et al., 2006). Briefly, the BALF was seed in 
DMEM and maintained in cell culture dish. Cells were incubated at 37°C in humidified air 
with 5% CO2 for 1 hour. The dish then was washed 3 times with PBS, and the adherent cells, 
predominantly macrophages, were collected for protein extract. 
 
2.2.12 Human tissue specimens 
Formalin-fixed, paraffin-embedded anonymous human lung tumor tissues were obtained from 
82 patients at the Hospital of University of Münster, Germany.  According to the WHO 
classification, tumor specimens were classified as squamous cell carcinoma in 37 patients and 
adenocacinoma in 45 patients. Lung tissues obtained from 3 healthy donors were used as 
controls. Clinical TNM staging was performed according to the IUCC/AJCC 
recommendations (Sobin and Fleming, 1997). None of these patients received prior radiation 
or chemotherapy. 
 
2.2.13 Preparation of cell nuclear protein extract 
Quiescent human peripheral blood monocyte derived macrophages (2×106 cells) and A549 
cells (1×106 cells) were co-incubated in 6-well plates as described in 3.2.6. Cell lysates and 
nuclear extracts were prepared 1 hour after co-culture and/or CSE stimulation using nuclear 
extract kit (Active motif, Carlsbad, CA, USA). The protocol was as followed: The medium 
was aspirated out of the 6 wells plates and the trans-wells and cells were washed 3 times with 
2 ml ice-cold PBS containing phosphatase inhibitors. Cells were removed from trans-wells 
and plates by gently scraping with a cell scraper and transfered to 1.5 ml microcentrifuge 
tubes; the cells were centrifuged for 5 min at 3000 rpm at 4ºC, supernatants were discarded 
and 200 μl 1X hypotonic buffer were added. The suspensions were mixed by pipetting up and 
down, and incubated for 15 min on ice. 10 μl detergent were added and the suspensions were 
vortexed for 10 seconds at highest setting and centrifuged for 60 seconds at 13000 rpm at 4ºC. 
Supernatants were discarded and 20 µl of the lysis buffer (10 mM DTT, Lysis Buffer AM1, 
Protease Inhibitor Cocktail) were added. The suspensions were vortexed for 10 seconds at 
highest setting and cell lysates were incubated for 30 min on ice and centrifuged for 15 min at 
13000 rpm (4ºC). Supernatants (nuclear protein) were collected and protein concentrations 
were measured with a BCA protein assay kit (Thermo scientific, Rockford, IL, USA). 
Proteins were frozen at -80°C for further detection. 
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2.2.14 Preparation of cell total protein extract 
Lung tumor nodules were carefully microdissected using an 18G needle from lungs under a 
microscope. 10 mg tumor nodule were homogenized in the 500 ul cell lysis buffer (Cell 
Signalling Technology, Danvers, MA, USA) containing 5mM PMSF and protease inhibitors 
(Roche, Mannheim, Germany) using rotor-stator homogenizer (IKA works. Inc, Wilmington, 
NC, USA). CSE or TNF treated A549 cells were washed 3 times in PBS, the pellets were 
lysed in the cell lysis buffer containing 5mM PMSF and protease inhibitors. For ELISA assay, 
the entire tumor-bearing lung was used. Lungs were homogenized in 2 ml cell lysis buffer 
containing 20 mM Hepes (pH 7.8), 100mM NaCl, 1% NP-40, 5mM PMSF, and protease 
inhibitors using rotor-stator homogenizer. After 60 min incubation on ice, homogenates were 
cleared by centrifugation for 15 min (13,000 rpm at 4°C). Protein concentrations were 
measured with BCA protein assay kit, and proteins were frozen at -80°C. 
 
2.2.15 Western blot 
For western blot analysis, 30 g total protein or 5 g nuclear protein extracts were mixed with 
2× loading buffer, and were then loaded on 10-12% SDS-polyacrylamide gels, subjected to 
electrophoresis at a constant power of 150 V. The separated samples were blotted onto 
nitrocellulose membrane (Bio-Rad, Hercules, CA, USA) at a constant power of 100 V for 2.0 
hours. After transfer, the membranes were blocked with 5% skim milk in TBS buffer for 1 
hour, incubated with a specific antibody against the indicated protein in TBS-T /5% skim 
milk overnight at 4°C. Subsequently, membranes were washed 3 times in TBS-T (3×10min) 
and were incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit, anti-goat or 
anti-mouse secondary antibody for 1 hour at room temperature. After three 10-minute washes 
of membranes with TBS-T, detection was performed by an enhanced chemiluminescence kit 
(Cell Signalling Technology, Danvers, MA, USA) according to the manufacturer’s instruction 
on Kodak scientific imaging films (Eastman Kodak, Rochester, N.Y., USA). Primary 
antibodies used for western blot analysis included: goat anti-LaminB (1:500), rabbit anti-p65 
(1:40000), mouse anti-cyclinD1 (1:5000), mosue anti-c-jun (1:1000) (all three from Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-STAT3 (1:10000), rabbit anti-
STAT3(pTyr705) (1:1000), rabbit anti-c-myc (1:500),  rabbit anti-Erk (1:1000) 
(pThr202/Tyr204), rabbit anti-total -catenin (1:1000), rabbit anti-GSK3 (pSer9) (1:1000), 
and rabbit anti-Akt (pSer473) (1:2000) (all seven from Cell Signalling Technology, Danvers, 
MA, USA), mouse  anti-unphosphorylated -catenin (1:1000) (Millipore, Temecula, CA, 
USA), mouse anti-PCNA (1:10000) (Abcam, Cambridge, UK) and mouse anti--actin 
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(1:40000) (Sigma Aldrich, Steinheim, Germany). Secondary antibodies include HRP-
conjugated goat anti-rabbit (1:2000) (Abcam, Cambridge, UK), rabbit anti-mouse secondary 
antibody (1:1000) (Dako, Glostrup, Denmark) or HRP-conjugated donkey anti-goat (1:1000) 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). 
 
2.2.16 Real time RT-PCR 
The entire tumor-bearing lungs were homogenized in the 3 ml Trizol reagent (Invitrogen, 
Carlsbad, CA, USA) using rotor-stator homogenizer. Human primary macrophage, A549, and 
RAW264.7 cells were lysed in the 1 ml Trizol reagent. Total RNA was isolated according to 
manufacturer’s recommendations. 1.5 g of total RNA was reverse transcribed using the 
First Strand cDNA synthesis kit (Fermentas, St. Leon-Rot, Germany) applying oligo(dT)18. 
cDNA was diluted 1:9 and 5 μl was used as template in a 25-mL SYBR-Green-PCR mix. 
Real-time PCR was performed using the SensiMix SYBR & Fluorescein Kit (Bioline, 
Luckenwalde, Germany) on iCycler machine (Bio-Rad, Munich, Germany). The amplication 
condition was: 
 
 Cycle Temperature Time 
polymerase activation 1 95°C 15 min 
denaturation 
anneal 
extension 
45 
95°C 
Tm 
72°C 
30 sec 
30 sec 
45 sec 
final extension 1 72°C 3 min 
denaturation 1 95°C 1 min 
start-temperature 1 55°C 1 min 
melt temperature 80 55°C (+0.5°C /cycle) 10 sec 
hold  10°C ∞ 
 
Specificity of RT-PCR was controlled by ‘‘no reverse transcription’’ controls and melting 
curve analysis. Quantitative PCR results were obtained using the ΔΔCT (cycle threshold) 
method. Data were normalised to -actin or GAPDH levels in each sample. 
 
The following PCR primers (Metabion, Martinsried, Germany) were used: 
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Name Sense primer Antisense primer Tm 
mouse -actin 5’-AGCCTCGCCTTTGCCGA-3’ 5’-CTGGTGCCTGGGGCG-3’ 60℃ 
mouse TNF 5’-AGCCCCCAGTCTGTATCCTT-3’ 5’-CTCCCT TTGCAGAACTCAGG-3’ 60℃ 
mouse IL-6 5’-CCGGAGAGGAGACTTCACAG-3’ 5’-TC CACGATTTCCCAGAGAAC-3’ 60℃ 
mouse CRAMP 5’-AATTTTCTTGAACCGAAAGGGC-3’ 5’-TGTTTTCTCAGATCCTTGGGAGC’ 60℃ 
human 
GAPDH 
5’-AGGTCGGAGTCAACGGATTTGGT-3’ 5’-GTGCAGGAGGCATTGCTGATGAT-3’ 60℃ 
human LL-
37/hCAP18 
5’- CCACCATGGGCCTGGTGATGCCT 
CTGGCCATC-3’ 
5’- TGTACACTAGGACTCTGTCCTGGGTACAAG-3’ 59℃ 
human 
Cyp27B1 
5’- ACCCGACACGGAGACCTTC-3’ 5’-CACAGGTGCG ACAACTGGTA-3’ 60℃ 
human VDR 5’- AAGGACAACCGACGCCACT-3’ 5’- ACACAC CTGTAGCCGTACTA-3’ 60℃ 
human TNF 5’-CCCAGGCAGTCAGATCATCTTC-3’ 5’-AGCTGCCCCTCAGCTTGA 60℃ 
human IL-6 5’-TCACCAGGCAAGTCTCCTCATTG 5’-ACTCCTTCTCCACAAGCGCCTT-3’ 58℃ 
human IL-8 5’-TGCAGCTCTGTGTGAAGGTGCAGT 5’-TGAATTCTCAGCCCTCTTCAAAAACTTC-3’ 58℃ 
 
 
2.2.17 Histologic and immunohistochemical analyses 
Mice were euthanized and the lungs were removed and infused with 4% paraformaldehyde, 
then immediately immersed in 4% paraformaldehyde before embedding in paraffin. Tissues 
were embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E). Other 
sections were prepared for immunohistochemical analysis. Sections were incubated at 60°C 
overnight and were deparaffinized. Sections were heated in microwave oven at 100°C for 20 
min in 0.01 M citrate buffer (pH 6.0) for antigen retrieval. Unspecific tissue peroxidases were 
blocked by 3% (v/v) H2O2 followed by incubation in blocking solution (2% BSA in TBS-T) 
for 60 min to prevent nonspecific binding. Slides were incubated with primary antibodies at 
4°C overnight. Secondary antibody incubation and staining were performed using the 
EnVision
®
+ System–HRP (AEC) kit (Dako, Carpinteria, CA, USA) according to 
manufacturer’s recommendations. The sections were counterstained with hematoxylin. The 
following antibodies were used: rabbit anti-CD68 (for mouse, 1:200, Abbiotec, San Diego, 
CA, USA), mouse anti-CD68 (1:100) (for human, 1:100, DAKO, Glostrup, Denmark), rabbit 
anti-TNF, mouse anti-Ki-67 (1:100) (all two from Abcam, Cambridge, UK), and 
mouse anti-unphosphorylated -catenin (1:50) (Millipore, Temecula, CA, USA), rabbit anti-
CRAMP (1:10000) (Pineda-Antikörper-Service, Berlin, Germany).  The number of CD68-
positive stained cells in randomly selected lung tumors was counted and the mean values were 
calculated. The number of Ki-67-positive tumor cells and the total number tumor cells was 
measured in six microscopic fields of randomly selected tumor and then the mean value was 
calculated as the percentage of Ki-67-positive tumor cells.  
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3.2.18 Cytokines ELISA assay  
Samples were prepared as described above. Before measuring cytokines, the total protein 
concentrations were measured with BCA protein assay kit and adjusted to the same total 
protein concentration. TNF, IL-6, and KC were measured by commercially available 
sandwich-type ELISA (R&D Systems, Minneapolis, MN, USA). 
 
3.2.19 Statistical analysis 
Values are displayed as mean plus or minus SEM. Comparisons between groups were 
analyzed by the t test (two-sided) or ANOVA for experiments with more than two subgroups 
or Kaplan-Meier survival analysis. Results were considered statistically significant for P 
values less than 0.05.  
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3 Results 
 
3.1 Macrophages promote proliferation of lung cancer cells and cigarette smoke 
increases this effect 
 
To determine the effect of macrophages on proliferation of lung cancer cells, transwell inserts 
were used in a co-culture model. After 5 days of co-culture, human macrophages derived 
from peripheral blood monocytes increased the growth of the lung cancer cell line A549 (Fig. 
6A). Furthermore, addition of different concentrations of CSE (0.1 %, 0.25 %, 0.5 %) to the 
co-culture enhanced macrophage induced growth of A549 cells (Fig. 6A). Carboxyfluorescein 
succinimidyl ester (CFSE) is a fluorescent dye that is used to identify cell division by its 
intensity determined by flow cytometry. After each round of cell division, relative 
fluorescence intensity of the dye is decreased by half.  Cell division of A549 cells was 
strongly promoted by co-culture with macrophages (Fig. 6B). In response to CSE treatment, 
the cell division rate of A549 cells co-cultured with macrophages was further increased (Fig. 
6B). 
To assess whether macrophage induced growth of A549 cells was due to altered cell 
proliferation, BrdU incorporation which incorporates into newly synthesized DNA strands of 
actively proliferating cells was detected using anti-BrdU antibodies ELISA assay kit. 
Consistent with the changes in the number of cells and mitotic activity, DNA synthesis of 
A549 cells was remarkably increased when cells were co-cultured with macrophages. 
Incubation with CSE enhanced this effect (Fig. 6C).  
 
 
 
 
 
 
 
 
 
 
 
 
A 
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C 
Figure 6: Macrophages promote proliferation of lung cancer cells and cigarettes smoke increase this 
effect 
Cells were rendered quiescent by serum starvation for 24 h. Thereafter, for the co-culture of A549 cells 
with macrophages, human peripheral blood monocyte-derived macrophages (4×104 cells) were placed in 
transwell inserts and A549 cells (2×104 cells) were seeded on the bottom of 12-well plates. The cells were 
exposed to indicated concentration of CSE for 5 days. EGF was used as control. (A) The proliferation of 
lung cancer cells A549 was measured by cell number count. (B) Cell division of A549 cells was analyzed 
by FACS (carboxyfluorescein succinimidyl ester, CFSE labeling). (C) Cell proliferation was measured by 
ELISA (5-bromodeoxyuridine, BrdU labeling) analysis. Results are means ± SEM, significant difference,* 
p<0,05;** p<0,01; *** p<0,001; ns, not significant. 
B 
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3.2 CSE induces NF-B activity and NF-B-dependent expression of pro-inflammatory 
factors in coculture of macrophages and A549 cells  
 
It has been shown that CS exposure induces lung inflammation by activation of transcription 
factor NF-B (Yang et al., 2006b). NF-B activation plays a pivotal role in regulation of 
inflammatory processes which are associated with inflammation-promoting tumor growth 
(Karin et al., 2006; Pikarsky et al., 2004). In order to examine whether the NF-B signalling 
pathway is activated after co-culture of macrophages with lung cancer cells and after CSE 
incubation, nuclear translocation of the NF-B subunit p65/RelA was detected by western 
blot analysis of nuclear protein extracts of macrophages. As shown in figure 7A, the levels of 
p65/RelA protein were increased in nuclei of macrophages after 1 h of co-culture with A549 
cells. Addition of CSE further increased translocation of p65/RelA protein into nuclei of 
macrophages. Interestingly, co-culture with macrophages and addition of CSE also increased 
NF-B activation in A549 cells (Fig. 7B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NF-B is known to be central in the induction and regulation of inflammatory responses. 
Next, the effect of co-culture and CSE exposure on the NF-B-dependent release of pro-
inflammatory factors including TNF, IL-6, and IL-8 was determined. When A549 cells were 
treated with CSE for 8 hours, there was no effect on the release of TNF, IL-6, and IL-8, 
p65/RelA 
 
Lamin 
B 
 
Lamin 
B 
 
Human macrophage A549 cell 
A B 
Figure 7: NF-B-p65 activation in macrophages and A549 cells. 
Quiescent human peripheral blood monocyte-derived macrophages (2×106 cells) and A549 cells (1×106 
cells) were co-incubated as described in Fig 6. Nuclear extracts were prepared 1 hour after co-culture 
and/or CSE exposure and were analyzed by western blot. Lamin B served as loading control. (A) human 
macrophage. (B) A549 cells. 
 
p65/RelA 
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compared to controls (Fig. 8A-C). In contrast, there was an increased release of TNF and IL-
8 when macrophages were treated with CSE whereas IL-6 levels were not affected (Fig. 8A-
C). Moreover, when both macrophages and A549 cells were present, the production of TNF, 
IL-6, and IL-8 was remarkably up-regulated and CSE further increased the release of these 
pro-inflammatory factors after 8 hours of treatment (Fig. 8A-C). To understand which type of 
cell is responsible for the release of pro-inflammatory factors when macrophages were co-
cultured with A549 cells, mRNAs expression patterns were analysed in both cell types. 
Interestingly, as determined by real-time PCR, co-culture or co-culture combinated with CSE 
incubation strongly induced Tnf, Il6, and IL8 gene expression in macrophages as well as in 
A549 cells indicating that both cell types contributed to the enhanced release of pro-
inflammatory factors (Fig. 8D-F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
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3.3 Inhibition of NF-B activation reduces macrophage-promoted tumor cells 
proliferation 
 
To examine the effect of NF-B on proliferation of tumor cells, the NF-B activation 
inhibitors Bay 11-7085, 6-Amino-4-(4-phenoxyphenylethylamino) quinazoline (QNZ) or 
pyrrolidine dithiocarbamate (PDTC) were used to prevent NF‑B transcriptional activity. 
After 5 days of co-culture, the NF-B activation inhibitor Bay 11-7085 or QNZ reduced 
macrophage induced proliferation of A549 cells compared to control levels, even though 
0.5% CSE exposure from results of cell count, BrdU and CFSE analyses (Fig. 9A-C). Next, 
these results were confirmed by western blotting of protein extract of A549 with or without 
NF-B activation inhibitor. Cell cycle protein cyclinD1 was decreased after treatment with 
Bay 11-7085, QNZ or PDTC in A549 cells. Addition of 0.5% CSE failed to protect cyclinD1 
protein reduction (Fig. 9D).  
Because addition of NF-B activation inhibitor in co-culture, NF-B activation were 
inhibited both macrophages and A549 cells. To further define the role of NF-B in 
macrophages, stable U937 cell lines containing short hairpin RNA (shRNA) specific to 
p65/RelA were generated (Fig. 9E).  p65/RelA silenced U937 cells (U937 p65ko) or mock 
E F 
Figure 8: Macrophage and CSE induce expression of pro-inflammatory factors. 
A549 cells and human peripheral blood monocyte-derived macrophages were co-cultured and were 
exposed to indicate concentration of CSE for 8 h in DMEM without FBS. (A) TNF (B) IL-6 and (C) IL-8 
levels in culture supernatants of A549 cells, of macrophages, and of macrophages co-cultivated with A549 
cells were analyzed by ELISA. Induction of the inflammatory cytokines (D) Tnf (E) Il6 and (F) Il8 was 
measured by real-time PCR. Total RNAs of A549 cells and macrophages were isolated 8 hours after CSE 
exposure. Mean fold change ± SEM, significant difference,* p<0,05;** p<0,01; *** p<0,001; ns, not 
significant. 
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U937 (U937 control) cells were co-cultures with A549 cells. After 5 days of co-incubation, 
silencing of p65 in U937 inhibited co-culture induced proliferation of A549 cells compared 
with mock U937 cells even when 0.5% CSE was added  (Fig. 9F-H).  
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Figure 9: Inhibition of NF-B activation reduces proliferation of A549 cells. 
A549 cells and human macrophages were treated for 1-2 hours with Bay 11-7085 (10uM) or QNZ (50nM) 
before co-culture and/or CSE stimulation. Cells were exposed to 0.5 % CSE for 5 days. EGF was used as 
control. Proliferation of A549 cells was analyzed by (A) cell number count, (B) BrdU assay, and (C) CFSE 
assay after 5 days co-culture and/or CSE exposure (D) A549 cells were co-cultured with human 
macrophages and were exposed to 0.5 % CSE or air for 5 days in NF-B inhibitor (10uM Bay 11-7085, 
50nM QNZ, 20uM PDTC) contained medium. A549 cell lysates were analyzed by immunoblotting for 
expression of CyclinD1 protein. (E) U937 cells were transfected with p65 shRNA plasmid or with a 
nonspecific control shRNA plasmid. After selection, expression of p65 was analysed by immunoblot. 
Proliferation of A549 cells induced by U937 control cells, U937 p65ko cells and/or CSE was analyzed by 
(F) cell number count, (G) BrdU assay and (H) CFSE assay after 5 days of co-culture and/or CSE exposure. 
Results are means ± SEM, significant difference, * p<0,05; ** p<0,01; *** p<0,001; ns, not significant. 
H 
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3.4 Generation of a lung cancer metastasis model in mice 
 
A lung cancer metastasis model in mouse was established by intravenous injection of LLC 
cells. LLC cells were derived from mouse Lewis lung carcinoma. To evaluate the success of 
the model, LLC cells were injected through the tail vein into female C57/BL6 mice at a 
concentration of 2 or 5×10
5
 cells in 200 l DMEM or DMEM alone per mouse. 15 days later, 
mice were sacrificed, their lungs were weighed and the tumor nodules on the lung surface 
were counted. Tumor formation was confirmed by light microscopy using hematoxylin and 
eosin (H&E) staining (Fig. 10.A). In contrast to controls, lung weights and tumor nodules 
increased in a LLC cell number dependent manner (Fig. 10B). Mice survival times were 
assessed for a period of 8 weeks and showed that the life span of tumor-bearing mice were 
shortened when given a higher LLC inoculum (Fig. 10C).   
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3.5 Smoke induces inflammation dependent on myeloid RelA/p65 
 
NF-B/RelA plays a key role in inflammatory and immune responses. In immune cells, NF-
B is a critical regulator for the expression of cytokines and chemokines (Perkins and 
Gilmore, 2006; Grivennikov and Karin, 2010a). To assess the contribution of RelA/p65 to CS 
induced lung inflammation, rela
Δ-/-
 mice were used that specifically lack RelA/p65 in the 
myeloid lineage. The initiation and progression of inflammatory responses require 
B 
C 
Figure 10: Evaluation of mouse lung cancer metastasis model  
(A) Lung appearance (up) and histology (H&E stain; down) in C57/BL6 mice 15 days after LLC 
inoculation with indicated cell numbers or DMEM. (B) Lung weight and the numbers of tumour 
nodules detectable on the lung surface were determined and statistically analyzed 15 days after 2 
or 5×10
5
 LLC cells were injected into C57/BL6 mice. Results are means ± SEM, n=6, ** p<0,01; 
*** p<0,001. (C) Survival curves of C57/BL6 mice injected with indicated cell numbers or 
DMEM via the tail vein (p<0,001; Log-rank test for statistic analysis; n=8). 
C 
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inflammatory factors which are primarily derived from myeloid cells including alveolar 
macrophages. Western blot analysis of proteins of alveolar macrophages obtained from rela
Δ-/- 
mice showed the p65 deletion in these cells and displayed a truncated form of RelA/p65 
(Δp65) compared to relawt/wt LysMCre (WT) mice (Fig. 11A). 
To examine the role of myeloid RelA/p65 in CS-induced lung tumor proliferation, 7 days 
after intravenous injection of 2 or 5×10
5 
LLC cells into 8-10week-old sex-matched rela
Δ-/- 
mice and WT mice via the tail vein, the mice were exposed to mainstream cigarette smoke 
(MCS) generated from burning cigarettes for 20 minutes each time, 5 times per day for 7 days. 
24h after the last CS exposure, mice were sacrificed and their lungs were removed for 
inflammation and cell proliferation analysis. In addition, after a 7 day rest interval, mice were 
sacrificed for lung tumor growth analysis. Control groups were incubated with filtered air (Fig. 
11B).  
To investigate the role of myeloid cells in the CS induced pulmonary inflammation, 
inflammatory cells and mediators in lungs of mice were characterized. CS exposure 
significantly increased the total cell number and absolute numbers of macrophages, 
neutrophils, and lymphocytes in BALFs of WT and myeloid RelA/p65 deficient mice as 
compared to air exposed mice (Fig. 11C). The concentrations of various inflammatory factors, 
such as IL-6, KC, and TNF-were significantly increased after CS exposure in the lungs of 
WT mice but not in lungs of myeloid RelA/p65 deficient mice (Fig. 11D). These data show 
that while depletion of myeloid RelA/p65 does not impact the influx of inflammatory cells 
into the lung after smoke challenge, myeloid RelA/p65 mediates the release of inflammatory 
mediators such as pro-inflammatory cytokines in the inflamed lung.  
 
 
 
 
 
 
 
 
 
 
 
 
A B 
                                                                                                                                          Results 
 47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 Myeloid RelA/p65 is necessary for metastatic lung tumor growth 
 
Next, it was investigated whether the CS induced inflammatory response contributes to lung 
tumor growth. Tumors were generated by injection of 2×10
5 
LLC cells in WT mice and rela
Δ-
/-
mice, followed by 7 days of CS exposure and a 7 day rest interval (Fig. 11B). Lung weights 
C 
Figure 11: CS-induced inflammation is dependent on myeloid cell RelA/p65 
(A) Expression of p65 and truncated p65 (Δp65) in alveolar macrophages of WT mice and relaΔ-/- mice. The 
expression of -actin was used as internal control for the amount of proteins. (B) Schema of experimental 
protocol of CS-induced inflammation or growth of tumor. (C) BALF of WT mice and rela
Δ-/- 
mice (inoculated 
with 5×10
5
 LLC cells through the tail vein) were collected 24h after last CS or air exposure. Cellular 
composition was evaluated using cytospin preparations. (D) Secretion of inflammatory cytokines in tumour-
bearing lungs of WT mice and rela
Δ-/- 
mice (5×10
5
 LLC cells inoculation) 24h after the last CS-exposure was 
analyzed by ELISA. Fresh lungs were homogenized, centrifuged and supernatants were analyzed. Results are 
means ± SEM, n=5, significant difference, *** p<0,05.  
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and the numbers of tumor nodules were determined at day 21. WT mice exposed to CS 
exhibited significantly increased lung nodule numbers and lung weights as compared to the 
air exposure control animals (Fig. 12A-C). In contrast, deletion of RelA/p65 in myeloid cells 
significantly reduced lung tumor nodule numbers and lung weights in air and smoke exposed 
mice (Fig.2A-C). H&E staining confirmed the massive increase of tumor load in WT mice 
exposed to CS and the significant reduction of tumor growth in rela
Δ-/-
mice (Fig.12A). In 
addition, the survival rate of tumor injected WT and rela
Δ-/- 
mice exposed to air or CS was 
examined. Deletion of p65 in myeloid cells resulted in increased survival (Fig.12D). There 
was no difference in the survival rate of air- or CS-exposed WT mice or rela
Δ-/- 
mice (Fig. 
12D). Taken together, RelA/p65 in myeloid cells is required for lung tumor growth.  
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3.7 Myeloid depletion of RelA/p65 results in decreased secretion of TNF-alpha from 
alveolar macrophages 
 
Macrophage infiltration is an important characteristic of tumorigenesis and there is correlation 
between macrophages abundance and poor prognosis (Murdoch et al., 2008). To investigate 
whether recruitment of myeloid cells into tumors depends on RelA/p65, the infiltration of 
macrophages in tumor nodules was examined by immunostaining using CD68 as macrophage 
marker. CS exposure was associated with increased numbers of macrophages in the tumor 
areas (Fig. 13A,B). RelA/p65 ablation did not significantly alter the recruitment of 
macrophage as compared to WT mice (Fig. 13A,B). 
TNF- is a major pro-inflammatory cytokine released by macrophages in a NF-B 
dependent manner and is implicated in the regulation of tumor growth (Takahashi et al., 2010; 
Oguma et al., 2008). As TNF- was reduced in the lungs of relaΔ-/-mice (Fig. 11D), 
immunostaining was used to determine whether TNF- expression in myeloid cells is altered 
in mice with dysfunctional RelA/p65. In mice exposed to CS, expression of TNF- in 
myeloid cells was increased, while rela
Δ-/-
mice revealed much weaker TNF- levels (Fig. 
13C). These data suggest that cytokine released from myeloid cells regulate tumor growth. 
 
Figure 12: Myeloid cells-specific RelA/p65 truncation inhibits CS-promoted growth of lung cancer  
(A) Macroscopic and microscopic pathology (H&E stain) of lung after LLC inoculation in WT or rela
Δ-/-
mice 
with or without MCS exposure. 2×10
5
 LLC cells were intravenously injected into sex-matched WT mice and 
rela
Δ-/-
mice, 7 days later, mice were smoked for 7 days, at day 21, the lungs were removed. (B,C) Lung 
weights and the numbers of tumor nodules detectable on the lung surface were determined. Results are means 
± SEM, n=5, significant difference, *** p<0,05. (C) Survival curves of mice (p<0,001; Log-rank test for 
statistic analysis; n=8). 
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3.8 Myeloid cell RelA/p65 activates a proliferation program in cancer cells 
 
To investigate whether CS-induced inflammation impacts on tumor cell biology, tumor cell 
proliferation was examined by immunohistochemical analysis of the proliferation markers Ki-
67. The numbers of Ki-67-positive cells were higher in CS-exposed tumors as compared to 
tumors of air exposed animals (Fig. 13D,E). Staining for Ki-67 in tumors of rela
Δ-/-
 mice was 
reduced as compared to WT mice (Fig. 13D,E).  
To follow up the results of the pathway analysis, we investigated whether these pathways 
are activated dependent on myeloid NF-B. Tumors were generated by injection of 5×105 
LLC cells and mice were sacrificed 24h later of last CS exposure. Tumors were carefully 
microdissected using needles from lungs, lysed, and examined by immunoblotting. In contrast 
to the air exposure group, expression of cyclin D1 and c-myc, which regulate the progression 
from G1 to S phase, were induced in response to CS treatment in lung tumors of WT mice 
E 
Figure 13: Myeloid cell RelA/p65 is required for TNF-expression in macrophages and proliferation of tumor 
cells.  
(A) Tumor bearing mice were exposed to air or MCS and lungs were removed, fixed and paraffin embedded 24h later 
of last MCS exposure. Paraffin-embedded tumour-bearing lung sections were analyzed by anti-CD68 antibody 
immunohistochemical analysis. Scale bars= 100m. (B) The numbers of CD68-positive cells in randomly selected 
lung tumour were counted. Results are means ± SEM of 5 high-power fields, n=5, significant difference, ** p<0,01; 
*** p<0,001; ns, not significant. (C) Immunohistochemical analysis of TNF expression in MCS or air-treated lung 
tumours of WT mice and rela
Δ-/- 
mice.  Scale bars= 100m. (D) Tumors were examined by immunostainingwith anti-
Ki-67-antibodies to detect proliferating cells. Bar = 100 µm. (E) Percentage of Ki-67-positive tumor cells. Results are 
means ± SEM, n=5, significant difference,* p<0.05; *** p<0,001.  
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(Fig.14A). CS exposure also increased the expression of PCNA (Fig. 14A). Immunoblot 
analysis of tumor lysates of WT mice revealed upregulation of c-jun, ERK phosphorylation, 
STAT3 and STAT3 phosphorylation in lung tumors after CS exposure (Fig.14A). Truncation 
of RelA/p65 in myeloid cells significantly reduced the expression of cyclin D1, c-Myc, and 
PCNA as well as the activation of STAT3 and c-jun in tumor cells (Fig.14A). Interestingly, 
no changes on ERK phosphorylation in lung tumor upon ablation of RelA/p65 in myeloid 
cells was observed (Figure 14.A) indicating that CS accelerates Erk phosphorylation in lung 
tumor independent of the myeloid FB signalling pathway.  
Wnt/-catenin signaling plays important roles in embryonic development and 
tumorigenesis (Oguma et al., 2008; Reya and Clevers, 2005). Therefore, it was investigated 
whether myeloid RelA/p65 is involved in the regulation of Wnt/-catenin signaling in lung 
tumors. Unphosphorylated -catenin was examined in lung tumors of WT mice and relaΔ-/-
mice by immunostaining. There was a strong staining in the tumor cells of WT mice after CS 
exposure (Fig.14B). rela
Δ-/- 
mice showed decreased staining for unphosphorylated-catenin 
in the tumors of both the air exposure and CS groups (Fig.14B). These results were confirmed 
by immunoblot analysis for unphosphorylated-catenin in tumor lysates (Fig.14C). These 
data show that myeloid RelA/p65 regulates tumor cell proliferation and activates growth 
signaling cascades. 
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Figure 14: Myeloid cell RelA/p65 is necessary for induction of proliferation and of survival signaling 
pathways in tumor cells. 
Tumours bearing mice were exposed to air or CS. Lungs were removed, fixed and paraffin embedded 24h 
after the last CS exposure. (A) Excised lung tumors were analyzed for the expression and phosphorylation of 
the indicated proteins by immunoblot analysis. (B) Expression of unphosphorylated -catenin was examined 
by immunohistochemical analysis in tumor-bearing lung sections of WT mice and rela
Δ-/-
mice. Bar=100 µm. 
(C) Isolated lung tumors were analyzed for expression and unphosphorylation of -catenin.  
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3.9 Macrophage TNF-alpha activates Wnt/-catenin signaling through GSK3andAkt 
 
To dissect the cellular pathways involved in myeloid RelA/p65 induced Wnt/ß-catenin 
signaling in cancer cells, in vitro tissue coculture models were performed. We examined the 
presence of unphosphorylated-catenin using human peripheral blood monocyte-derived 
macrophage and A549 cells. Consistent with in vivo results, macrophages mediated the 
activation of -cateninin in cancer cells in response to CSE (Fig.15.A), whereas CSE did not 
show a significant increase of unphosphorylated-cateninin levels in A549 cells that were not 
co-cultured with macrophages (Fig. 15.A). Konckdown of p65 in U937 cells by shRNA 
reduced accumulation of unphosphorylated-cateninin in A549 cells (Fig. 15.B). These 
findings suggest RelA/p65 in macrophages is required for promotion of Wnt/-catenin 
signalling in cancer cells. 
   To evaluate whether macrophage released TNF-is responsible for Wnt/-catenin 
activation, lung cancer cells (A549) were directly stimulated with TNF-. Administration of 
TNF- significantly increased the accumulation of unphosphorylated-cateninin in A549 
cells after 4 hours (Fig.15C). Addition of a neutralizing antibody against TNF- significantly 
suppressed macrophage-induced accumulation of unphosphorylated-cateninin in A549 cells 
(Fig. 15D). These results show that TNF- release from macrophages is required and 
sufficient for the activation of the Wnt/-catenin pathway in cancer cells. 
GSK3 has been shown to phosphorylate -catenin leading to its degradation via the 
ubiquitin pathway (Oguma et al., 2008, Kaler et al., 2009). Furthermore, Akt has been 
reported to be involved in Wnt signaling by phosphorylating GSK3at Ser9 (Oguma et al., 
2008, Sharma et al., 2002).  Therefore, it was analyzed whether TNF- phosphorylates 
GSK3or Akt.A549 cells were treated with TNF- and proteins were analyzed for GSK3 
phosphorylation on Ser9 and Akt phosphorylation on Ser473. TNF-exposure resulted in 
phosphorylation of GSK3andAkt in A549 cells (Fig. 15C). These results suggest that TNF-
 promotes the Wnt/-catenin pathway by phosphorylation of GSK3and the activation of 
the Akt pathway.
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3.10 The Wnt/-catenin signaling pathway is active in human NSCLC cells 
 
To investigate whether the described mechanisms and pathways are relevant in patients, we 
analyzed human lung cancer samples by immunohistochemical detection of macrophages 
(CD68), TNF- and unphosphorylated -catenin. Sections of healthy lung tissue, 
adenocarcinomas, and squamous cell carcinomas were stained. While sections of healthy lung 
tissue showed weak signals for unphosphorylated-catenin, LC sections revealed positive 
staining for unphosphorylated-cateninin in tumor cells toghether with the presence of CD-
68 positive cells (Fig. 16). Staining for TNF-revealed a strong expression in myeloid cells 
in the tumor stroma. These data shows that the principal pathways described in the present 
study are active in human disease and are likely relevant for disease progression.  
 
 
 
D
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Figure 15: TNF- released from macrophages activates-cateninin through GSK3and Akt 
pathways.  
(A) A549 cells were co-cultured with human peripheral blood monocyte-derived macrophage and were 
exposed to 0-5%CSE for 72h. A549 cell lysates were analyzed by immunoblotting for the abundance of 
unphosphorylated -catenin. (B) P65 was knocked down in U937 cells by shRNA and the effect on A549 
cells was determined by detection of unphosphorylated -catenin by immunoblotting. (C)A549 cells were 
treated by 100 ng/ml TNF- for the indicated times. Expression of the indicated protein was detected by 
immunoblotting analysis. (D) TNF- blocking antibody (10g/ml) was applied to CSE-exposed A549 
cells incoculture with human peripheral blood monocyte-derived macrophage. After 72h, the indicated 
proteins in A549 cells were analyzed by immunoblotting.  
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3.11 The cathelicidin CRAMP promotes metastatic lung tumor growth  
 
The previous results indicate that the human cathelicidin LL-37 acts as a growth factor for 
human lung cancer cells and promotes tumor cell growth (Von Haussen, et al., 2008). To 
investigate the role of CRAMP in lung metastatic carcinomas and CS-induced tumor 
promotion, the metastatic lung cancer model was used in which tumors were generated by 
injection of 2×10
5 
LLC cells in CRAMP knockout mice (CRAMP
-/-
) and in littermate control 
mice (CRAMP 
wt/wt
) followed by 7 days CS exposure and a 7 days’ rest interval. Control 
groups were incubated with filtered air. Lung weights and number of tumor nodules were 
determined at day 21. There was a dramatic increase in lung nodule number and lung weight 
Figure 16: NSCLCs in humans reveal macrophage infiltrations and abundant -catenin 
accumulation. Tissue section of healthy lung tissue, adenocarcinomas, and squamous cell carcinomas 
were stained with antibodies against CD68, TNF- and unphosphorylated -catenin. CD68, Bar = 200 
µm; TNF- and unphosphorylated -catenin, Bar = 100 µm. 
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(Fig. 17A) in lungs of CRAMP 
wt/wt
 mice that were exposed to CS relative to air exposure 
control animals. Furthermore, CRAMP deficiency resulted in reduced lung tumor nodule 
numbers and lung weight. There was no enhanced tumor growth in CRAMP
-/- 
mice exposed to 
CS (Fig. 17A). H&E staining showed that the tumor load of lungs of CS-exposed CRAMP 
wt/wt
 mice were much higher compared to lungs of air exposed mice and CRAMP
-/- 
mice (Fig. 
17B). In addition, immunohistochemical staining for the proliferation marker Ki-67 showed 
that the number of Ki-67-expressing cells was higher in CS-exposed CRAMP 
wt/wt
 tumors 
compared to air exposed CRAMP 
wt/wt
 mice and CRAMP
-/- 
mice indicating that CS does not 
induce proliferation of tumor cells in CRAMP
-/- 
mice (Fig. 17C, D). Furthermore, CS exposure 
shortened the life time of CRAMP 
wt/wt
 mice and CRAMP
-/-
 mice exhibited longer survival 
times than CRAMP 
wt/wt
 mice (Fig. 17E). There was no difference in the survival rates of air- 
or CS-exposed CRAMP
-/-
 mice (Fig. 17E). These data show that ablation of CRAMP in mice 
results in reduced smoke induced tumor proliferation and tumor promotion. 
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Figure 17: CRAMP deletion decreases MCS-promoted growth of lung cancer 
 (A) 2×10
5
 LLC cells were intravenously injected into sex-matched CRAMP 
wt/wt
 mice and CRAMP
-/- 
mice. 
At day 7, mice were smoked for 7 days, at day 21, the lungs were removed. The numbers of tumor nodules 
detectable on the lung surface and lung weight were determined. (B) Lungs of CRAMP 
wt/wt
 and CRAMP
-/-
 
21 days after LLC cell inoculation (2×10
5
 cells) with or without MCS exposure. Lung appearance (up) and 
histology (H&E stain; down). (C) Tumor-bearing lungs were removed, fixed and paraffin embedded 24h 
later of last MCS exposure. Proliferating cells were examined in lung tumors of CRAMP 
wt/wt
 mice and 
CRAMP
-/- 
mice by immunostaining with anti-Ki-67-antibodies in paraffin-embedded sections. Scale bars= 
100m. (D) The percentage of Ki-67-positive tumour cells among all tumour cells. Results are means ± 
SEM, n=5, significant difference,** p<0,01; *** p<0,001.  (E) Kaplan-Meier survival analysis of the 
indicated mouse strains injected with 2×10
5
 LLC cells via the tail vein exposed to either CS or air 
(p<0,001; Log-rank test for statistic analysis; n=7). 
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3.12 CRAMP is required for CS induced influx of myeloid cells into the lung  
 
It is well established that cathelicidins function as chemoattractants for immune cells (Coffelt 
et al., 2009; Kurosaka et al., 2005). It was hypothesized that cathelicidins play a role in the CS 
induced recruitment and infiltration of immune cells into the lung and into tumor tissue 
thereby promoting tumor proliferation and progression. The total cell number as well as the 
number of macrophages, neutrophils, and lymphocytes was increased after CS exposure in 
BALFs of CRAMP 
wt/wt
 mice compared to air exposed mice, whereas CS exposure did not 
induce the influx of myeloid cells into the lungs of CRAMP
-/-
 mice (Fig. 18A). In addition, the 
infiltration of macrophages into lung tumors was increased in CRAMP 
wt/wt
 mice but not in 
CRAMP
-/-
 mice after CS exposure as shown by immunohistochemistry (Fig. 18B). These data 
show that CRAMP plays a critical role in directing myeloid cells into the lung and into tumot 
tissue after smoke exposure.  
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3.13 CS-induced recruitment of CRAMP-positive immune cells depends on myeloid 
RelA/p65 
As indicated above, CS induces lung cancer proliferation through activation of myeloid NF-
B and subsequent release of inflammatory factors that promote tumor growth. Furthermore, 
it has been shown that NF-B signalling pathway is involved in cathelicidin regulation and 
function (Li et al., 2009). To examine whether NF-B/RelA mediates the influx of CRAMP-
positive immune cells into the lung and into tumor tissue we exposed rela
Δ-/-
 mice to CS. 
Litter mates (WT) were used as control. The relative CRAMP mRNA expression in metastatic 
carcinomas was compared between air and CS-exposed mice. CS exposure resulted in an 
increased expression of CRAMP in the lungs of WT mice compared to air exposed mice, 
whereas CS exposure did not result in enhanced expression levels of CRAMP in rela
Δ-/-
 mice 
(Fig. 19.A). Furthermore, immunohistochemistry showed that expression levels of CRAMP in 
B
 Air  
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Figure 18: CRAMP ablation reduces MCS-induced recruitment of immune cells into mice lung.  
(A) Tumors bearing CRAMP 
wt/wt
 and CRAMP
-/-
 mice were exposed to air or MCS. BALFs were collected 24h after 
the last MCS or air exposure. Cellular composition was evaluated using cytospin preparations. Results are means ± 
SEM, n=5, significant difference,* p<0,05;** p<0,01; *** p<0,001; ns, not significant. (B) Tumour-bearing lungs 
were removed, fixed and paraffin embedded 24h later of last MCS exposure. Paraffin-embedded tumour-bearing lung 
sections were analyzed by anti-CD68 antibody immunohistochemical analysis. Scale bars= 100m.  
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tumor cells was considerably weak, almost un-measurable, whereas myeloid cells infiltrated 
into the tumor tissue expressed remarkably higher levels of CRAMP (Fig. 19.B). The number 
of CRAMP-positive myeloid cell was significantly increased in the tumor tissue of WT mice 
after CS exposure, but not in rela
Δ-/-
 mice (Fig. 19.B). We also found that CS exposure 
increased the number of CRAMP-positive immune cell in noncancerous lesions region (Fig. 
19.C). These results indicate that RelA/p65 is required for the influx of CRAMP-positive 
immune cells into tumor tissue.  
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3.14 Cancer cells mediate the CS induced expression of the human cathelicidin LL-
37/hCAP-18 in macrophages  
 
To demonstrate that CS induces the expression of cathelicidin in human tissue, human 
macrophages derived from peripheral blood monocytes were co-cultured with A549 cells. 
After 48 hours co-incubation with A549 cells, the induction of human cathelicidin LL-
37/hCAP18 mRNA was increased in macrophages and was further enhanced by CSE in a 
dose dependent manner (Fig. 20.A). In A549 cells, the expression of LL-37/hCAP18 mRNA 
remained constant even when the cells were exposed to CSE, co-culture with macrophages or 
C
 Air  
Figure 19: Expression of CRAMP and CRAMP-positive immune cells infiltration in WT mice and 
rela
Δ-/- 
mice.  
(A) CS exposure increases the expression of CRAMP gene whereas myeloid cell RelA/p65 deletion 
decreases CS-induced CRAMP induction. Lung total RNA was isolated 24h after last CS exposure and 
analyzed by real-time PCR. Mean fold change ± SEM, n=5, significant difference, ** p<0,01 versus air 
control. (B,C) Presence of CRAMP-positive immune cells in lungs of air- and MCS-exposed tumor-
bearing mice. Lung sections prepared 24 h after last CS exposure of mice were analyzed by 
immunostaining for CRAMP. (B) tumor. (C) Noncancerous lesions region. Scale bar = 100 μm. 
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co-culture with macrophages in combination with CSE (Fig. 20.B). Interestingly, 
macrophages that were treated with CSE alone did not show elevate expression of LL-
37/hCAP18 mRNA suggesting soluble factors produced by A549 cells mediating the 
expression of this peptide. 
It has been shown that the vitamin D receptor (VDR) mediates the expression of LL-
37/hCAP18 mRNA in human macrophages (Liu, et al., 2006, Gombart, et al., 2005). 
Therefore, the regulation of the VDR was investigated in human macrophages upon co-
incubation with A549 cells. In agreement with expression of LL-37/hCAP18 mRNA, an 
increase of VDR mRNA in macrophages was observed when co-cultured with A549 cells and 
exposed to CSE (Fig. 20.C). Likewise, Cyp27B1 mRNA levels were up-regulated in co-
cultured and CSE exposed macrophages (Fig. 20.D). Cyp27B1 catalyzes the conversion of 
inactive provitamin D3 hormone (25-hydroxyvitamin D3; 25(OH)D3) into the bioactive form 
(1,25-dihydroxyvitamin D3; 1,25(OH)2D3). Like LL-37/hCAP18 expression, no observable 
up-regulation of VDR and Cyp27B1 mRNA was seen in CSE-treated macrophages without 
the presence of A549 cells. In addition, macrophages were treated with various concentrations 
of 1,25(OH)2D3 and LL-37/hCAP18 mRNA expression was assessed. 1,25(OH)2D3, strongly 
induced LL-37/hCAP18 gene expression in dose-dependent manner (Fig. 20.E). Taken 
together, these results suggest that the CSE induced expression of LL-37/hCAP18 is mediated 
by lung tumor cells involving vitamin D activated signalling pathways. 
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3.15 Regulation of CRAMP expression  
 
In contrast to LL-37/hCAP18, the transcriptional mechanism that regulates CRAMP gene 
expression is not clear. Since TLR2 and biglycan, a small leucine-rich proteoglycan, have 
been shown to mediate host innate immunity (Schaefer et al., 2005; Kim et al., 2009), it was 
Figure 20: A549 cells in combination with CSE induce LL-37/hCAP18 and relative genes expression in 
macrophages and A549 cells. 
(A,B) A549 cells co-culture with human peripheral blood monocyte-derived macrophages and then were 
exposed to 0-0.5%CSE for 48h in 6-well plates. Total RNA were isolated from macrophages and A549 cells, 
and gene expression was assessed by real-time PCR. Expression of LL-37/hCAP18 mRNA in macrophages 
(A) and A549 cells (B). Expression of VDR (C) and Cyp27B1 (D) mRNA in macrophages were assessed by 
real-time PCR. (E) Regulation of LL-37/hCAP18 mRNA on stimulation with 1,25(OH)2D3 for 24h. Mean fold 
change ± SEM, * p<0,05;** p<0,01; *** p<0,001; ns, not significant. 
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hypothesized that these extracellular signals might induce CRAMP gene expression. The 
mouse macrophage cell line RAW264.7 was treated with different concentrations of serum-
free conditioned medium from LLC cells (LLC CM), biglycan, and TLR2-TLR6 ligand 
Pam2CSK4. As determined by real-time PCR, conditioned medium from LLC induced a 
significantly high expression of the CRAMP gene in RAW264.7 cells in a LLC cell number-
dependent manner (Figure 21A). Biglycan did not induce the expression of CRAMP (Fig. 
21C). In addition, Pam2CSK4 induced up-regulation of the CRAMP gene in RAW264.7 cells. 
The effect was slight and rather high doses of Pam2CSK4 were required indicating the 
induction of this gene is likly independent in TLR2 or TLR6 (Fig. 21B). It was also found that 
induced expression of TNF and IL-6 mRNA in RAW264.7 cells (Fig. 21A). In Pam2CSK4 
treated macrophages, a strong increase of TNFmRNA expression was observed as well as a 
weak induction of IL-6 mRNA (Fig. 21B). Additionally, the induction of CRAMP was not 
observed after treatment with inflammatory factors such as TNF, IL-1, and INFfor 24 
hours (Fig. 21C). Taken together, these data suggest that tumor-derived inflammatory factors 
mediate expression of CRAMP in macrophages; however, which factor or factors mediate the 
regulation of CRAMP needs to further inestigated in the future. 
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Figure 21: Induction of CRAMP mRNA expression by conditioned medium from LLC cells and 
various inflammatory factors. 
 (A) RAW264.7 cells were treated with LLC cells conditioned medium for 24 hours. CRAMP, TNF 
and IL-6 mRNA expression were analyzed by Real-time PCR. Medium were collected from 2×, 4×, and 
6×10
6
 cells/10cm dish. (B) RAW264.7 cells were cultured with Pam2CSK4 (100ng /ml and 1000ng/ml) 
for 24 hours, CRAMP, TNF and IL-6 mRNA expression were measured. Mean fold change ± SEM, ** 
p<0,01; *** p<0,001; ns, not significant. (C) RAW cells were treated with the indicated compounds for 
6 and 24 hours, and CRAMP mRNA expression was analyzed by Real-time PCR. Mean fold change ± 
SEM, ns, not significant. 
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4 Discussion 
   
The main finding of the present study was: (i) smoke-induced pulmonary inflammation 
increases lung cancer proliferation in vivo and in vitro and that RelA/p65 of myeloid cells 
contributes to promotion of lung tumor cells by increasing cell proliferation; (ii) One crucial 
pathway comprises RelA/p65-derived TNF induces and subsequent activation of Wnt/-
catenin signalling in tumor cells; (iii) cathelicidin promote cigarette smoke-induced lung 
carcinoma proliferation, it is associated with the recruitment of immune cells and activation of 
myeloid NF-B. 
A strong association of inflammation with cancer has been supported by clinical and 
experimental observations (Coussens and werb, 2002, Yoshimura, et al., 2006). Inflammation 
is suggested to cause DNA alterations and induces oncogenic mutations by the production of 
reactive oxygen and nitrogen species, which result in tumor initiation (Grivennikov, et al., 
2010, Takahashi, et al., 2010). Furthermore, inflammation promotes tumor progression via 
inflammatory cytokines produced by infiltrating immune cells such as macrophages and 
neutrophils (Grivennikov, et al., 2010). It has been shown that interaction between neoplastic 
cells and their close surrounding that includes macrophages, granulocytes, dendritic cells and 
lymphocytes are crucial to each step of tumorigenesis (Coussens and werb, 2002, Yoshimura, 
et al., 2006). These immune cells have a remarkable ability to produce pro-inflammatory 
mediators, such as TNF and IL-6, which can serve as mitogens and survival factors for 
tumorigenesis and tumor promotion (Grivennikov, et al., 2010).  
It has been reported that chronic inflammation induced by cigarette smoke, asbestos or 
silica is clearly linked to development of cancer (Yoshimura, et al., 2006). Pulmonary 
disorders such as COPD, a chronic airway inflammatory disease induced by microbial 
infection or cigarette smoke, are associated with the greatest risk for lung cancer (Walser et al., 
2008; Punturieri et al., 2009). Particulate material from cigarette smoke and other irritants    
induce injury and chronic lung inflammation and contribute to the development of lung cancer 
(Grivennikov et al., 2010; Punturieri et al., 2009). However, most of the research focuses on 
the role of CS and chronic inflammation as tumor initiators. Whether CS or CS induced 
inflammatory responses are tumor promoters remains poorly understood.  
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4.1 Cigarette smoke enhances lung tumor promotion by inducing pulmonary 
inflammation 
 
Cigarette smoke is the most important risk factor for lung cancer, which is associated with 
about 85-90% of cases (Jemal et al., 2003). Even though the carcinogenicity of CS has been 
successfully shown in several animal experiments, it is still poorly understood whether this 
complex mixture also has tumor-promoting effects (D'Agostini et al., 2001; Witschi et al., 
2002).  In this work, a mouse model is described in which CS exposure has a strong tumor-
promoting effect on metastatic lung cancer cells. It is shown that cigarette smoke increases 
lung cancer promotion in mice inoculated with LLC cells. The in vivo results are supported 
by in vitro experiments. It is shown that cigarette smoke remarkably enhances macrophages 
induced growth of the lung cancer cell line A549 cells. The data of this study clearly proof 
that co-culture of cancer cells with human macrophages leads to an increased growth of A549 
cells. Macrophages which are activated in response to CS are considered to be a major source 
of inflammatory cytokine (Yang et al. 2006b). The increased growth of tumor cells was be 
correlated with an induction of pro-inflammation cytokines. 
Several factors can contribute to tumor promotion, whereas inflammation induced 
elevation of inflammatory cytokines that promote proliferation and survival of malignant cells 
is likely to be a major tomor-promoting mechanism (Karin, 2006). It is currently thought that 
pro-inflammatory effects induced by cigarette smoke contribute to the development of COPD 
and lung cancer (Walser et al., 2008). In this study, the presence of a subacute inflammatory 
pulmonary response in mice exposed to CS is demonstrated. It is shown that cigarette smoke 
challenge results in an increase of total cells in BALF, including macrophages, neutrophils 
and lymphocytes. Especially macrophages are associated with tumor promotion. CS induces 
the induction and release of TNF, IL-6, and KC in mice lung tissues. Previous reports 
showed that macrophages of the lung have an important role in the inflammatory responses 
seen in smoker and COPD patients and their number correlates with disease severity (Barnes, 
et al., 2003; Yang, et al., 2008; Vlahos et al., 2006). Macrophages can be activated by 
cigarette smoke or tumor derived factors, such as versican, resulting in the production of 
inflammatory mediators, such as TNF, IL-6 and IL-8 (Yang et al. 2006b; Kim et al., 2009). 
Here, it is shown that both cigarette smoke exposure and co-culture with A549 cells increases 
TNF IL-6, and IL-8 releases from macrophages. However, what is noticeable is that the 
treatment of combination of CS and A549 cells resulted in a higher release of TNF, IL-6, IL-
8 from macrophage than stimulation of CSE or A549. Therefore, cigarette smoke and lung 
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cancer cells synergistically induce the expression of pro-inflammatory factors in macrophage. 
Interestingly, the tumor cell line A549 also showed increased expression of TNF, IL-6, and 
IL-8, suggesting that tumor cells itself are involved in inflammation induced tumor promotion 
within the tumor microenvironment.  
In this study, we evaluated macrophage infiltration into lung cancer tissue. It is shown that 
mouse lung tumors had more infiltrating macrophages after CS exposure compared with 
tumors of air control groups indicating that macrophage infiltration might contribute to CS-
induced lung tumor growth. It is further shown that the presence of infiltrating macrophages 
is remarkable higher in human NSCLC than healthy lung. Previous reports have shown a 
close association between macrophage infiltration and poor prognosis in cancer (Ono, 2008, 
Moghaddam, et al., 2008). However, a correlation between extensive TAM infiltration and 
poor prognosis in lung cancer is contradictory (Pollard, 2004). For example, Koukourakis et 
al. found that high TAM infiltration were associated with a poor prognosis in 141 cases of 
early stage I-II NSCLC (Koukourakis et al., 1998), whereas Kerr et al. showed that there is a 
better correlation between tumor regression and high TAM number from comparison of 28 
regressing NSCLC cases and 67 control cases (Kerr et al., 1998). Different approaches used in 
TAM assessment may contribute to these contradictory results in the mentioned lung cancer 
studies (Bingle et al., 2002).  
 
4.2 NF-B activation is crucial in inflammation promoted lung tumor proliferation  
 
Activation of NF-B is responsible for the induction of a variety of target genes that are 
important for tumorigenesis (Yoshimura et al., 2006). NF-B activation in inflammatory cells 
controls the production of pro-inflammatory cytokines, including TNF, IL-1, IL-6, and IL-
23, which mediate tumor promotion and progression, as well as NF-B activation in tumor 
cells (Karin and Greten, 2005; Grivennikov and Karin, 2010a). NF-B activation also is 
found in tumor cells where it regulates cell proliferation, survival, angiogenesis, invasion, and 
metastasis (Luo et al., 2004; Grivennikov and Karin, 2010b; Naugler and Karin, 2008). The 
results shown in this study report that NF-B activation is present in macrophages and lung 
cancer cells in an artifical tumor microenvironment. Tumor cells can induce NF-B activation 
in macrophage and macrophage also activate NF-B in tumor cell indicating that both cell 
types contribute to cancer development. Furthermore, cigarette smoke enhances the activation 
of NF-B in macrophages and cancer cells, which is needed for tumor promotion.  
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RelA/p65 is an important component of classical NF-B pathway and forms a dimer with 
p50. Upon activation of the classical NF-B pathway, the RelA/p65:p50 dimer translocates to 
the nucleus resulting in the transcription of many genes encoding cytokines, chemokines, pro-
angiogenic factors, adhesion molecules, and antiapoptotic proteins (Karin and Greten, 2005; 
Yoshimura, 2006). Here, a murine model with rela
F/F 
LysMCre (rela
Δ-/-
) mice that have a 
truncated myeloid RelA/p65 gene was used (deletion of exons 7-10 of rela gene) (Algul et al., 
2007; Hess C et al., 2010; Clausen et al., 1999) to demonstrate that the activation of RelA/p65 
in myeloid cells is required for CS-induced promotion of lung cancer. It is shown that 
myeloid truncation of RelA/p65 in rela
Δ-/- 
mice resulted in a nearly complete abrogation of CS 
induced tumor promotion as well as in strongly decreased expression of NF-B dependent 
proliferative genes in tumor cells, such as PCNA, CyclinD1 and c-Myc. It is further shown 
that a reduced release of pro-inflammatory cytokines, including TNF, IL-6 and IL-8, in 
rela
Δ-/- 
mice. Interestingly, RelA/p65 deletion did not perturb recruitment of macrophages to 
the tumors suggesting that factors released by macrophages and not the influx of macrophages 
into tumor tissue itself, stimulate the proliferation of tumors. Additionally, it there was a 
decreased STAT3 activation in lung tumor cells of CS or air exposed rela
Δ-/- 
mice, which is 
likely to be a major effect of  declining release of IL-6 from lung. This finding is supported by 
earlier reports showing that IL-6 produced by lamina propria myeloid cells enhances 
proliferation of tumor-initiating cells and protects premalignant intestinal epithelial cells from 
apoptosis through transcription factor STAT3 mediation (Grivennikov et al., 2009). These 
results strongly suggest that RelA/p65 dependent production of inflammatory cytokines in 
myeloid cells, such as TNF and IL-6, enhance lung tumor proliferation. 
 
4.3 The role of Wnt/-catenin signalling in cigarette smoke promoted lung cancer 
proliferation  
 
It has been shown that elevation of inflammatory factors from myeloid cells enhances the 
proliferation and survival of cancer cells, which is a major tumor promoting mechanism 
(Grivennikov et al., 2010, Takahashi et al., 2010). However, the mechanism how 
inflammatory mediators derived from myeloid cells promote tumor proliferation is not 
entirely clear (Kim et al., 2009). In this study, target oncogenes of Wnt/-catenin signalling, 
such as CyclinD1 and c-Myc, were activated in CS-induced lung tumor promotion, which 
attracted our attention. This study shows that Wnt/-catenin signalling is activated in cancer 
cells of NSCLC patients indicating that activation of this signalling pathway is most likely 
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involved in tumor growth. The animal experimental results clearly show that cigarette smoke 
promotes activation of Wnt/-catenin signalling in tumor cells of WT mice. A number of 
studies have shown that dysregulation of the Wnt/-catenin pathway is implicated in 
tumorigenesis (Reya and Clevers, 2005). In the lung, aberrant activation of Wnt/-catenin 
pathway is involved in pulmonary fibrosis and cancer transformation (Konigshoff and 
Eickelberg, 2010; Licchesi et al., 2008). Aberrant Wnt1/-catenin expression is an independent 
poor prognostic marker of non-small cell lung cancer after surgery (Xu et al., 2011) and Wnt1 
overexpression is associated with the expression of tumour-associated Wnt-targets, tumour 
proliferation, angiogenesis and a poor prognosis in NSCLCs (Huang et al., 2008). Increasing 
evidence suggests that promotion of the Wnt/-catenin pathway has an important role in 
tumor growth and progression (Fodde et al., 2007). Basbaum s´ research group reported that 
cigarette smoke induced malignant transformation of human bronchial epithelial cells is 
mediated by the activity of Wnt/-catenin and sonic hedgehog pathways (Lemjabbar-Alaoui 
et al., 2006). In our study, it was not found that cigarette smoke directly promotes Wnt/-
catenin signalling in the lung cancer cell line A549.  The cigarette smoke induced activity of 
Wnt/-catenin signalling may be a cell type-specific response.  
Moreover, the results of this study show that the presence of macrophages increases CSE 
induced activation of Wnt/-catenin signalling. The findings also suggest that RelA/p65 in 
myeloid cells (particularly in macrophages) is required for promotion of Wnt/-catenin 
signalling in cancer cells. Therefore, some soluble factor(s) released by macrophages in a NF-
B dependent manner are likely to be responsible for Wnt/-catenin activity in lung cancer 
cells. Accumulating evidence indicates that TNF is linked with inflammation-associated 
tumors (Greten, et al., 2004; Pikarsky, et al., 2004; Kim, et al., 2009). Importantly, in gastric 
tumor cells, Wnt/-catenin signalling is involved in TNF regulated tumorigenesis (Oguma, 
et al., 2008). Here it is shown that TNFstimulation promotes activation of Wnt/-catenin in 
A549 cells. Moreover, inhibition of Wnt/-catenin signalling by addition of TNF 
neutralizing antibody in CSE-stimulated co-cultures confirmed the function of TNF. 
GSK3 is a key player of the inhibition of the Wnt/-catenin pathway. GSK3 
phosphorylates a set of conserved Ser and Thr residues of -catenin, leading to its 
proteasomal degradation (Reya and Clevers, 2005; Moon, et al., 2004). Several experiments 
indicate that Akt can activate the transcriptional activity of -catenin by phosphorylation of 
GSK3(Oguma et al., 2008; Sharma et al., 2002). Here it is demonstrated that 
TNFactivates the Akt pathway and inactivates GSK3in lung tumor cells. This may 
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contribute to promotion of Wnt/-catenin pathway activity. Accordingly, the present results 
suggest that cigarette smoke induced release of TNFfrom myeloid cells mediated by NF-B 
pathway activation increases Wnt/-catenin signalling in tumor cells, which is responsible for 
lung tumor promotion.  
 
4.4 LL-37/hCAP18 is required for cigarette smoke induced lung carcinoma progression 
 
It has been characterized that LL-37 is secreted by immune and epithelial cells and acts as a 
pro-inflammatory peptide which links inflammation, host defence, tissue repair, and cell 
growth (Bucki et al., 2010). As described above, inflammation plays a pivotal role in tumor 
development and many of the immune cell-derived inflammatory molecules mediate this 
procession (Grivennikov et al., 2010). Antimicrobial activity is a major function of LL-37. It 
shields, for instance, mice from skin and urogenital infection and protects from tuberculosis 
(Nizet et al., 2001; Chromek et al., 2006; Liu et al. 2006). Considering that disrupting 
microbial cell membranes and/or inducing autolysis are mechanism of the antimicrobial 
activity of LL-37, it was suggested that similar action can be used to kill tumor cells (Bucki, 
et al., 2010). However, several studies found that LL-37 is over-expressed in human lung, 
breast, ovarian, and prostate cancer and a tumor-promoting effect of this peptide has been 
demonstrated (Von Haussen et al. 2008; Heilborn et al., 2005; Coffelt et al., 2008; Hensel et 
al., 2010). Previous reports from our laboratory showed that LL-37 is strongly expressed in 
human lung cancer cells and that the peptide promotes tumor growth by direct interaction 
with cancer cells (Von Haussen et al. 2008). This study further confirms the tumor promoting 
ability of CRAMP (the murine homolog of human LL-37) by using CRAMP deficient mice. 
In CRAMP deficient mice, the growth of lung tumors induced by the injection of LLC cells 
was inhibited. Moreover, this study shows that CS exposure increases the induction of 
CRAMP in mice lungs and demonstrates that the tumor-promoting effect of CS is decreased 
as a result of targeted deletion of CRAMP. These results indicate that cathelicidin has a close 
association with CS induced tumor promotion.  
Although the biologic role of LL-37 in tumor promotion has been partly elucidated, it 
remains unclear which pathway mediates the function of this peptide. The angiogenic effect 
of LL-37 is likely to be one mechanism of the cathelicidin dependent tumor growth. Previous 
studies showed that LL-37 induces functionally important angiogenesis by binding to the 
peptide to FPRL1 of endothelial cells (Koczulla et al., 2003; Steinstraesser et al., 2006). PLC-
g/PKC/NF-B, the Erk-1/2 MAPK, and the PI3K/Akt pathway are involved in the endothelial 
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activation elicited by LL-37 (Koczulla et al., 2003). Furthermore, the peptide regulates the 
vascularization in ovarian tumors and prostate cancer (Coffelt et al., 2009; Hensel et al., 2010). 
LL-37 may also affect tumor cells directly by stimulating cell growth. Previous reports 
showed that LL-37 treatment of lung cancer cell lines augments cell growth and indicate that 
involvement of EGFR pathway (Von Haussen et al. 2008). LL-37 treatment of lung cancer 
cells results in phosphorylation of EGFR and mitogen-activated protein kinase 
(MAPK)/extracellular signal-regulated kinase (ERK), principal factors of signalling pathways 
involved in tumor pathogenesis (Von Haussen et al. 2008). Additionally, activation of 
ERK1/2 and Akt pathway is also implicated in angiogenesis and cellular proliferation of 
prostate cancer (Hensel et al., 2010).  LL-37 stimulates growth of ovarian cancer cell lines 
depending on the presence of serum suggesting this peptide needs accessory or carrier 
proteins to execute its effects (Coffelt et al., 2008). Release and activation of MMP2 and 
MMP9 induced by LL-37 may reflect an invasion advantage for tumor cells, as these 2 MMPs 
are up-regulated in ovarian and prostate cancer cells (Coffelt et al., 2008; Hensel et al., 2010). 
It is currently thought that infiltration of tumors by inflammatory cells is important to 
tumor development. These cells regulate tumor growth by means of production of cytokines 
and chemokines that act in autocrine and paracrine manners (Grivennikov et al., 2010). The 
data presented here showed that CS exposure enhances the number of macrophages 
infiltrating into tumors, especially tumor margin, which serve to facilitate proliferation of lung 
tumor cells. Notably, deletion of CRAMP in mice reduces macrophage migration into tumors, 
and CS did not promote engraftment of these cells in CRAMP deficient mice. LL-37 has been 
shown to be a chemotactic factor which mediates multipotent mesenchymal stromal cells 
(MSCs) migration to tumors mediated by FPRL1 (Coffelt et al., 2009). Like LL-37, CRAMP 
also exhibits a direct effect on the migration of immune cells including monocytes, 
neutrophils, and macrophages (Kurosaka et al., 2005).  Thus, it is a possible explanation that 
LL-37 contributes to the promotion of lung tumor progression through recruitment and 
infiltration of inflammatory cells into tumor tissue in where these cells provide pro-
angiogenic and growth factors that support tumor growth and progression. 
Previous reports showed that LL-37 is expressed in various human lung cancer cell lines 
and in human lung cancer including large cell carcinoma, squamous cell carcinoma, and 
adenocarcinoma (Von Haussen et al. 2008). In this study, immunostaining for CRAMP in 
mouse lung tumor sections proved that CRAMP expression was much higher in inflammatory 
cells than tumor cells and that the number of cells positive for CRAMP increased in tumors 
after CS exposure. The in vitro studies demonstrated that the induction of LL-37/hCAP18 in 
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macrophages is up-regulated upon co-culture with A549 cells and that addition of CSE further 
enhances this peptide expression. These results indicate that CS exposure induces 
inflammatory cells contributing cathelicidin to the tumor microenvironment. This increase in 
peptide may then lead to further recruitment of immune cells into the tumor 
microenvironment. Additionally, high LL-37 levels secreted by inflammatory cells into a 
cytokine milieu may also influence tumor cell angiogenesis, proliferation, and invasion. 
Cytokines and growth factors, such as LPS, IL-1 and insulin-like growth factor-1 in 
keratinocytes, have been reported to induce LL-37/hCAP18 expression (Erdag and Morgan, 
2002; Sorensen et al., 2003). However, most of inflammatory mediators including TNF, IL-
6, IL-8, and INF-do not induce expression of LL-37/hCAP18 (Gombart et al.,2005). 
Gombart and co-works reported that VDR mediates a strong up-regulation of LL-37/hCAP18 
gene in response to treatment of cells with 1,25(OH)2D3 and its analogs (compound I 
(1,25R,26-(OH)3-22-ene-D3), KH1060 (20-epi-22oxa-24a,26a,27a-trihomo-1,25(OH)2D3) and 
EB1089 (1,25-dihydroxy-22,24-diene, 24,26,27-trihomo)) (Gombart et al.,2005). As VDR is 
expressed a wide range of tissues, including monocytes, neutrophils, and cell lines from lung 
as well as head and neck squamous cell carcinomas, it is likely that LL-37/hCAP18 can be 
induced in all of these tissues (Wang et al., 2004; Gombart et al.,2005). 1,25(OH)2D3 and its 
analogs  have been observed to induce expression of LL-37/hCAP18 in myeloid cells, acute 
myeloid leukaemia (AML), keratinocytes, and colon cancer cells (Gombart et al.,2005). 
TLR2/1 activation of human macrophages induces expression of VDR and Cyp27B1genes 
and is required for downstream LL-37/hCAP18 production (Liu et al., 2006). The data of this 
study show that lung cancer cells induce LL-37/hCAP18, VDR, and Cyp27B1gene expression 
in macrophages and that the combination with CSE results in a synergistic induction of these 
factors. It is further shown that CSE alone does not induce the expression of these 3 genes in 
macrophages. The results presented here provide a possible indication that tumor derived 
inflammatory mediators activate VDR and Cyp27B1 in macrophages and that Cyp27B1 
catalyzes the synthesis of 1,25(OH)2D3 from the precursor 25(OH)D3 leading to the induction 
of the antimicrobial peptide cathelicidin LL-37/hCAP18 via VDR. It is the role of CSE in this 
process to induce inflammation resulting in the up-regulation of inflammatory factors 
expression in macrophages and tumor cells.  
The induction of CRAMP by vitamin D3 does not occur in mice because of the absence of 
the VDRE in the murine CRAMP promoter (Gombart et al., 2005). The present data report 
that versican, an aggregating chondroitin sulphate proteoglycan, is up-regulated in lung cancer 
cells. Versican activates pro-inflammatory responses and induces TNF secretion by myeloid 
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cells in a TLR2, TLR6, and CD14 dependent manner leading to tumor metastatic growth 
(Kim et al., 2009). Furthermore, another extracellular matrix proteoglycan biglycan has been 
reported to act in macrophages as an endogenous ligand of TLR4 and TLR2, which mediate 
innate immunity and induce release of inflammatory mediator (Schaefer et al., 2005). 
Therefore, versican and biglycan potentially induce the CRAMP gene. Unfortunately, 
increased CRAMP expression after biglycan treatment in macrophages could not be observed. 
As versican is not available from commercial company, the regulation effect to CRAMP was 
not studied. Additionally, high doses of the TLR2-TLR6 ligand Pam2CSK4 only induced a 
weak up-regulation of CRAMP gene expression in macrophages suggesting that the induction 
of this gene is possibly independent of TLR2 or TLR6. In agreement with the regulation of 
the human cathelicidin LL-37/hCAP18, these data also show that TNF, IL-1, and INF fail 
to up-regulate mRNA expression of CRAMP in mouse macrophages. Analysis of the CRAMP 
gene sequence showed that a NF-B site is present at its promoter region, indicating NF-B 
might be implicated in regulation of CRAMP (Pestonjamasp et al., 2001). In support of this 
notion, the in vivo studies offer evidence that NF-B activation is involved in inflammation 
induced CRAMP up-regulation using a murine model of RelA/p65 deletion in myeloid cell. 
The binding sites of GM-CSF (granulocyte-monocyte colony stimulating factor) and NF-IL6 
(nuclear factor for IL-6) have been identified in the CRAMP gene. These sites might be 
candidates for regulation of expression (Pestonjamasp et al., 2001). The exact transcriptional 
mechanisms that regulate CRAMP gene expression need to be examined in future studies. 
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5 Conclusions 
 
To investigate the role of myeloid NF-B cells in lung cancer proliferation, an in vitro co-
culture model was established that mimicked the microenvironment of tumors. The impact of 
myeloid NF-B on tumor promotion was further studied in a murine lung cancer model 
which was established by intravenous injection of lewis lung carcinoma cells into mice that 
specifically lack RelA/p65 in the myeloid lineage.  Furthermore, an experimental smoking 
protocol was developed to study cellular mechanisms underlying cigarette smoke induced 
promotion of lung cancer.  
In this study, it is demonstrated that cigarette smoke exposure results in an inflammatory 
response of the lung characterized by elevated pro-inflammatory factors and the recruitment 
of macrophages and neutrophils into the lung. Cigarette smoke and lung cancer cells 
synergistically induced the expression of pro-inflammatory factors in macrophages. Moreover, 
cigarette smoke-induced inflammation remarkably enhanced lung tumor promotion and 
decreased the survival rate of mice due to increased proliferation in tumors. The role of 
myeloid NF-B in tumor promotion was investigated. Deletion of RelA/p65 in myeloid cells 
of mice impaired CS-induced inflammation in tumor-bearing lungs. Furthermore, rela
Δ-/- 
mice 
showed a longer survival and a nearly complete abrogation of CS-induced tumor promotion, 
as well as strongly decreased expression of NF-B-dependent proliferative genes such as c-
Myc, cyclin D1, and PCNA in tumor cells. In the in vitro co-culture model, inhibition of the 
NF-B pathway in macrophages also decreased inflammation-induced A549 cells growth. 
In addition, immunohistochemistry showed that the Wnt/-catenin signalling pathway is 
activated in cancer cells of NSCLC patients. This is in line with results obtained from animal 
experiments that showed that cigarette smoke promotes the activation of Wnt/-catenin 
signalling in tumor cells in mice. Furthermore, RelA/p65 in myeloid cells (particularly in 
macrophages) was required for promotion of Wnt/-catenin signalling in cancer cells. 
Cigarette smoke exposure increased the expression of TNFfrom myeloid cells in a NF-B 
dependent manner. TNF suppressed the phosphorylation of -catenin by phosphorylation of 
GSK3and the activation of the Akt pathway leading to Wnt/-catenin promotion. 
Cigarette smoke induced the expression and secretion of the cathelicidin CRAMP in mice 
lungs, especially in macrophages, and its action required the activation of myeloid RelA/p65. 
Deletion of CRAMP inhibited immune cell migration into the tumor microenvironment and 
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decreased lung tumor metastatic growth and CS tumor-promoting effects. Inflammation-
induced expression of LL-37/hCAP-18 in macrophages involves vitamin D receptor and 
Cyp27B1 activation shown in the in vitro co-culture model. 
Accordingly, the study presented here suggests that cigarette smoke-induced pulmonary 
inflammation increases lung cancer promotion and that RelA/p65 in myeloid cells contributes 
to the inflammation-induced promotion of lung tumor cells by increasing cell proliferation. 
The main findings of the present study are: (i) smoke-induced pulmonary inflammation 
increases lung cancer proliferation in vivo and in vitro and RelA/p65 of myeloid cells 
contributes to promotion of lung tumor cells by increasing cell proliferation; (ii) One crucial 
pathway comprises RelA/p65-induced TNF and subsequent activation of Wnt/-catenin 
signalling in tumor cells; (iii) cathelicidin promotes cigarette smoke-induced lung carcinoma 
proliferation, which is associated with the recruitment of immune cells and activation of 
myeloid NF-B. 
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